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ABSTRACT 
Porcine paramyxovirus (PPMV) was isolated from pigs experiencing a 
neurological and respiratory disease outbreak on a commercial pig farm in Southern 
Minnesotta. The virus has been shown to be infectious and pathogenic to swine. 
Antigenic studies determining cross reactivity have demonstrated reactivity with 
antibodies of parainfluenza viruses, PIV-1, PIV-3 and PIV-48. 
There has not been extensive investigation into the virion morphology and 
ultrastructure of the PPMV nucleoscapids, proteins, and nucleotide sequences of 
PPMV. Virions were purified by sucrose-gradient centrifugation. Electron microsopy 
of the purified virions and nucleocapsids revealed the pleomorphism of the virions 
and serrated nucleocapsids. 
To characterize the genome of PPMV we cloned the total RNA of PPMV-
infected cells and generated a cDNA library. The library was screened with a 
radiolabeled probe prepared from virus infected cells. One virus specific clone was 
identified and sequenced. Sequence analysis and comparison to previously 
published sequences of paramyxoviruses revealed that this clone was from the P 
gene of PPMV and had 98% homology with the P genes of parainfluenza virus 3 
(PIV-3) and bovine parainfluenza virus 3 (BPIV 3). The cloned gene will be 
beneficial in developing diagnostic tests for the detection of PPMV infections. 
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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
An investigation of a respiratory and a central nervous system (CNS) disease 
outbreak in a farrow-to-finish farm in Minnesota in1992 led to the isolation of a viral 
agent that was characterized to be a paramyxo-like virus (Janke et al., 1992). The 
virus was designated as ISU-92. This porcine paramyxovirus-like infection had an 
infectious nature. All 350 pigs in the first barn identified with the disease were 
affected and the infection appeared to gradually spread to the other barns on the site 
(Janke et al., 1992; Battrell et al., 1993). In addition, this disease presented as a 
fast spreading disease, within the barn and between barns on the site (Janke et al., 
1992; Battrell, 1995). In the initial barn where the infection was first noted, mortality 
was estimated at approximately 4% and the infection in subsequent barns produced 
high morbidity but no mortality (Janke et al., 1992; Battrell, 1995). The main clinical 
manifestations of the infected pigs were dyspnea, harsh barking cough and CNS 
disorders in the form of rear-end ataxia, intermittent head pressing, and whole body 
tremors (Janke et al., 1992; Battrell, 1995). 
An attempt to reproduce the infection in pigs with lung homogenates 
(20%w/v) from infected pigs failed. However, inoculation of three-day old piglets 
intranasally with cell culture propagated porcine paramyxovirus (PPMV) produced 
lesions of mild interstitial pneumonia and encephalitis characterized by multifocal 
gliosis and perivascular cuffing of the piglets (Janke et al., 1992). Studies on this 
virus were continued by Battrell et al. (1993) by using virus suspensions. Two forms 
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of the PPMV were demonstrated by electron microscopy, a spherical virion with a 
diameter of 250 nm and a filamentous form in virion suspensions (Battrell, 1995). 
Furthermore, PPMV was adapted for growth in five different cell lines (swine 
testis cells, PK-27 cells, porcine kidney cells and Mengeling Vaughn kidney cells) 
and plaque purified in PK-27 cells three times (Battrell, 1995). The growth curve of 
PPMV was determined in PSP-27 cells and a virus neutralizing test was developed 
for detecting the virus neutralizing antibodies based on inhibition of PPMV- induced 
cytopathic effect in monolayers of PSP-27. Then the pathogenicity of PPMV for 
specific pathogen free (SPF) pigs was demonstrated in one virus infected three-day 
old SPF pig (Battrell, 1995). 
With the standardized virus-neutralization test, an assessment of the 
seroprevalence of PPMV in sera bank from Iowa swine herds was made using 
stored sera collected during the period of 1988-1989 (Battrell, 1995). A total of 876 
serum samples collected within this period as part of the NAHMS Iowa Pilot project 
were screened. Only six (representing five swine herds) out of the 876 samples 
tested positive for the PPMV neutralizing antibodies. This indicated a probable low 
level of PPMV infection in 1988 and 1989. 
Purpose and Objectives of the Study 
The main purpose of the study was to further the understanding of the biology 
of PPMV, help further characterize it and finally lead to the development of a more 
sensitive diagnostic assay for detecting PPMV infections. The major objectives were 
to study the morphology of purified virions and nucleocapsids and to determine the 
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sequence information on selected gene for better characterization of PPMV and the 
development of diagnostic assays. 
Thesis Organization 
The thesis is organized into the following sections. The general introduction 
provides a brief introduction to the research and includes a statement of the purpose 
and objectives of the study, followed by review of the literature on paramyxoviruses. 
In the second chapter, we present data on the viral ultrastructure of the ISU-92 strain 
of PPMV, cloning and sequence of one gene of ISU-92. Our studies showed that 
the PPMV, ISU-92, is closely related to bovine parainfluenza virus type 3 and human 
parainfluenza virus type 3. The general conclusions are discussed in Chapter 3. A 
comprehensive list of the literature cited is provided at the end of the thesis. 
Literature Review on Paramyxoviruses 
The species that belong to the genus paramyxovirus are human 
parainfluenza virus 1 (HPIV 1 ), bovine parainfluenzavirus 3, human 
parainfluenzavirus 3 (HPIV 3), Sendai virus (murine parainfluenzavirus 3), and 
simian virus 3. The paramyxoviruses belong to the order Mononegavirales. This 
order is comprised of three families of viruses possessing linear, non-segmented 
negative sense ssRNA genomes, i.e., the Paramyxoviridae, Rhabdoviridae and 
Filoviridae (Bishop and Pringle., 1993). 
It has been shown that members of the genus paramyxovirus are RNA, 
enveloped viruses with helical nucleoprotein core (Compans and Choppin , 1967; 
Duesberg and Robinson, 1965; Hartley and Choppin 1968; Korzan, 1962; Nayak 
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and Saluda, 1967; Plowright, 1962; Pons, 1967; Sokal et al., 1966). By previous 
classifications, the general category of RNA viruses with helical symmetry and 
limiting membrane includes a variety of agents that resemble one another in 
superficial morphology but which differ markedly in other physical and biological 
properties (Burton, 1969). 
The myxoviruses were the first "natural" family of RNA viruses shown to 
possess helical ultra structure and an envelope. Other viruses found to share these 
structural attributes were, therefore, designated myxoviruses or myxovirus-like even 
though they may have lacked distinguishing properties of the group. The result was 
that the myxovirus family tended to denote a heterogeneous group of infectious 
agents, for many of which the family name had no meaning (Burton, 1969). 
The word myxovirus is derived from the Greek word (myxa) for nasal mucous 
and was coined as the group name because of the reaction of influenza and related 
viruses with mucoproteins (Andrews, 1962). The main characteristic of this group 
was defined by Andrews et al. (1955) as the affinity for mucoproteins and an 
enzyme-like reaction with these substances. This two-phase interaction occurs 
when mucoproteins are in a free state as in serum or when they are integral parts of 
cells such as erythrocytes (Burton, 1969). 
In the case where these mucoproteins are integral part of the cells, for 
example, erythrocytes, this characteristic activity of myxoviruses results in 
agglutination of erythrocytes. This is achieved by the attachment of the virus to the 
mucoprotein receptors on the cell surface and the resulting hemagglutination is 
followed by spontaneous elution of the virus with destruction of the erythrocyte 
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receptors due to a neuraminidase enzyme in the virus (Waterson and Almeida, 
1966; Burton, 1969). As specimen preparation techniques for electron microscopy 
improved, more viral agents were determined to possess an ultrastructure similar to 
some myxoviruses and were classified as members of the myxovirus group even 
though they lacked neuraminidase and, in some cases, were unable to 
hemagglutinate; for example, rinderpest, respiratory syncytial and distemper viruses 
(Waterson and Almeida, 1966). 
Due to the ability of some myxoviruses to hemagglutinate non-enzymatically 
and the lack of interaction by certain myxoviruses with erythrocytes, it was 
suggested to remove this property from the list of distinguishing characteristics of 
the group myxovirus (Andrews, cited in Waterson and Almeida.,1966). It was 
proposed to restrict the use of the name myxovirus to those RNA helical and 
enveloped viruses which exhibit the property of myxophily, as originally described by 
Andrews, and those agents which are structurally indistinguishable from the 
myxophilic viruses (Waterson and Almeida, 1966). The term true myxovirus, 
therefore, described those agents that demonstrated two-phase interaction with 
mucoproteins and possessed the ultrastructure of influenza or paramyxoviruses 
while "pseudomyxovirus" denoted those viruses which have the characteristic fine 
structure, but lack the two-phase myxophylic activity. Other RNA, helical, enveloped 
viruses that have neither interaction with mucoproteins nor distinctive myxovirus 
structure received no special designation (Burton, 1969). 
Based on the proposal and terminology of Waterson and Almeida ( 1966), the 
RNA, helical, enveloped viruses are classified into three groups: true myxoviruses, 
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pseudomyxoviruses and other RNA-helical enveloped viruses. The true myxovirus 
group is comprised of influenza viruses and paramyxoviruses. The 
pseudomyxoviruses consist of (a) measles, distemper, rinderpest virus group, (b) 
pneumovirus of mice, and (c) respiratory syncytial virus. The other RNA-helical 
enveloped virus group includes: (a) infectious bronchitis virus, (b) rabies-like viruses, 
(c) bovine viral diarrhea/hog cholera viruses, and (d) foamy virus (Burton, 1969). 
Morphology 
The virions of the viruses of the order Mononegavirales are large enveloped 
structures generally with a prominent fringe of spikes that are 5-10 nm long and 
spaced 7-10 nm apart. The morphology of the particles is variable but members of 
the three families can be distinguished from each other. The member viruses of the 
family Filoviridae are characterized by simple, branched, U-shaped, 6-shaped and 
circular filaments of uniform diameter. Filamentous, pleomorphic and spherical 
forms are characteristic of members of the Paramyxoviridae family. The member 
viruses of the family Rhabdoviridae are characteristically bullet-shaped or bacilliform 
(Bishop and Pringle, 1996). The helical ribonucleoprotein core has a diameter of 13-
20 nm which in filamentous forms and rhabdoviruses is organized into a helical 
nucleocapsid of about 50 nm diameter (Bishop and Pringle, 1996). 
Virions of the family Paramyxoviridae are pleomorphic but usually spherical in 
shape (Nagai et al., 1989; Rima et al., 1996). The size of the membrane spheres 
formed from portions of the cell membrane during budding when virions detach from 
cell membranes and the amount of virus precursors contained within it, in 
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conjunction with the other forces that act on the virions affect the size and shape of 
the virus particle. This accounts for the pleomorphism observed in the influenza 
virus (Stevenson and Biddlem, 1966). Three strains of the rinderpest virus grown in 
monolayers of tissue culture that were inactivated with 0.4% formaldehyde, 
concentrated 100-fold by ultra-centrifugation and examined by negative staining 
revealed the majority of virus particles to be circular and oval, but larger more 
irregular particles were also observed (Plowright, 1962). Two of the rinderpest virus 
strains produced filamentous forms of 300 to 500 A in diameter which may be up to 
1 OOOA long (Plowright, 1962). 
In the family Paramyxoviridae, the virions vary in size from 150-500 nm in 
diameter (Rima et al., 1996), with the occurrence of larger particles of 500-600 nm in 
diameter and long filamentous forms (Nagai et al. , 1989). The SV5, a simian 
parainfluenza virus, virions have a diameter of 120-460 nm (Compans and Choppin, 
1967). 
The virions consist of a lipid bilayer envelope which is derived from the 
plasma membrane of the host cell plasma membrane (Compan and Choppin, 1967; 
Lamb and Kolakofsky, 1996, Rima et al., 1996). The envelope is covered with 7-9 
nm long spikes projecting from the surface of the membrane (Compans and 
Choppin, 1967; Cornishark et al., 1962; Hilleman, 1962; Plowright 1962). The virus 
particles of the rinderpest virus are bound by well-defined membranes, with an outer 
layer of projections of about 90A in length (Plowright, 1962). Within the envelope is 
the central core which in the mumps virus, parainfluenza (Sendai) virus, Newcastle 
disease virus and parainfluenza viruses consists of a coiled hollow helix with the 
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outer diameter of 17 nm and internal diameter of 4-5 nm (Egelman et al., 1989; 
Hilleman, 1962). The coiled hollow helix is a single nucleocapsid, consisting of a 
single strand of RNA associated with a large number of nucleocapsid protein (NP) 
sub-units in a rod shaped helical structure (Compans and Choppin, 1967; Duesberg 
and Robinson, 1968; Egelman et al., 1989; Plowright, 1962). The nucleocapsid has 
helical symmetry and a pitch of 5.3 to 7 nm, and can be up to 1000 nm long 
(Egelman et al., 1989; Rima et al., 1996). 
Classification 
The genus paramyxovirus belongs to the order Mononegavirales. This order 
consists of three families of viruses possessing linear, non-segmented, negative 
sense single-stranded RNA genomes, namely Paramyxoviridae, Rhabdoviridae, and 
Filoviridae (Bishop and Pringle, 1996). For these three families, negative sense 
RNA, helical nucleocapsid, the initiation of primary transcription by a virion-
associated RNA dependent RNA polymerase, a similar gene order and a single 3, 
promoter are common features (Bishop and Pringle, 1996). Maturation of the virion 
is by budding from the plasma membrane and rarely from internal membranes as for 
the rabies virus or from the inner membrane as for many plant rhabdoviruses 
(Bishop and Pringle, 1996). 
The family Paramyxoviridae has been reclassified into two sub-families based 
on morphological criteria, genomic organization, biological activity of the proteins 
and sequence relationships: the Paramyxovirinae and the Pneumovirinae (Bishop 
and Pringle, 1996). The sub-family Paramyxovirinae consists of three genera: 
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Paramyxovirus, Rubulavirus and Morbillivirus, while the sub-family Pneumovirinae 
contains only one genus, the Pneumovirus. 
The morphological distinguishing features of the viruses grouped in the sub-
family Paramyxovirinae are the size and shape of the nucleocapsids, with a diameter 
of 18 nm, a length of 1 µm and a pitch of 5.5 nm (Egelman et al., 1989; Lamb and 
Kolakofsky, 1996). Within the genus, members exhibit antigenic cross-reactivity. 
Neuramininidase activity is present in Parainfluenza virus genus but is absent in 
morbillivirus. The P proteins coded for by the P gene differ between the genera and 
in the rubulavirus genus, an extra gene SH is present (Bellini et al., 1985; Lamb and 
Kolakofsky, 1996). 
Pneumoviruses differ from the paramyxoviruses by their narrower 
nucleocapsids, the number of encoded proteins and an attachment protein that is 
different from that of the paramyxovirus (Lamb and Kolakofsky, 1996). The 
distinguishing characteristics of each are shown in Table 1. 
Genome structure 
The genomic RNA of the family Paramyxoviridae has been shown to be of a 
high molecular weight with a sedimentation coefficient of 50S in sucrose gradients 
(Duesberg et al., 1965; Kingsbury, 1966; Kolakofsky et al., 1974; Lamb and 
Kolakofsky, 1996). The genome is a non-segmented single stranded molecule of 
RNA consisting of approximately 15,500 nucleotides (Blumberg et al., 1981; Elango 
et al., 1988; Griffith et al., 1992; Lamb and Kolakofsky, 1996; Nagai et al., 1989; 
Rima et al., 1996). 
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Table 1. Distinguishing characteristics between pneumoviruses and 
paramyxoviruses. 
Characteristic Paramyxoviruses Pneumovirus 
Genes 6-7 10 
Gene size Larger Smaller 
M2 protein M2 absent M2 present 
Extensive 0-linked glycosylation Absent Present 
of G protein 
Proteins encoded by P locus >One One 
Nucleocapsid diameter 18 nm 13-14nm 
Nucleocapsid pitch 5.5 nm ?nm 
Length of glycopprotein spike 8nm 10-12 nm 
Hemagglutinin Present Absent 
Neuraminidase Present Absent 
- ---- ·- -- ---- - --- - --- --- --
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In the sub-family Paramyxovirinae, the genome contains 6-7 genes that 
encode 10-12 proteins (Rima et al., 1996). Nearly all of the proteins are encoded by 
unique RNAs except for the P, C and V mRNAs which are synthesized by a 
mechanism involving the site-specific stuttering (editing) on the same template 
(Linne et al., 1992; Nagai et al., 1989; Rima et al., 1996). A characteristic feature of 
the paramyxovirus P gene is that it is transcribed to a single mRNA which is read in 
two independently initiated overlapping reading frames coding for the P and C 
proteins (Berg et al., 1992; Georgi et al., 1983; Shioda et al., 1983 and 1986). The P 
gene of the La Piedad Michoacan virus (LPMV) has been found to have two ORFs 
of about equal length which overlap in the middle region and a third ORF encoding 
126 amino acids (Berg et al., 1992). 
The gene order of the six genes common to all the genera of the sub-family 
Paramyxovirinae has been demonstrated to be: 3' leader, NP or N, P, M, F, HN, L, 
5' trailer (Chambers et al., 1986; Elango et al., 1988; Linne et al., 1992; Lamb and 
Kolakofsky, 1996; Nagai et al., 1989; Rima et al., 1996; Shioda et al., 1986). 
Variations in gene order occur in certain genera or species when F0 and HN0 occur 
as precursors for F and HN proteins as in Newcastle disease virus (Nagai et al., 
1989) or by differences in the coding potential of the P gene to give PN or P/C order 
of genes (Berg et al., 1992; Lamb and Kolakofsky, 1996; Rima et al., 1996). In the 
genus Pneumovirus the 1 C, 1 B proteins in that order precede the N protein, 1 A and 
G are located between M and F proteins with 22K located between F and L proteins 
(Lamb and Kolakofsky, 1996). 
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There are conserved transcriptional and control sequences that are copied 
into mRNA at the beginning and at the end of each gene. lntragenic regions exist 
between genes which are three nucleotides long for the parainfluenza viruses and 
morbilliviruses but are of variable length for rubulaviruses (Nagai et al., 1989; Rima 
et al., 1996). All the LPMV genes are terminated by the conserved sequence (in the 
positive sense) of UUUAAGAAAAAA (Berg et al., 1992). 
Proteins 
The viruses grouped in the subfamily Paramyxovirinae contain six to seven 
genes that encode 10-12 proteins (Orvell, 1978; Rima et al., 1996; Sanchez and 
Banerjee, 1985; Sundqvist et al., 1990). The phosphoprotein (P) gene has been 
shown to code for 4 or 5 (or more) of these proteins from 2-3 overlapping ORFs 
(Berg et al., 1992; Ohgimoto et al., 1990). Virion proteins common to all genera 
include the three nucleocapsid associated proteins (an RNA-binding protein NP, a 
phosphoprotein P and a large polymerase protein L), three membrane associated 
proteins (an unglycosylated envelope protein Mand two glycosylated envelope 
proteins, fusion protein F and an attachment protein G or Hor HN (Rima et al., 
1996). 
For the LPMV at least six 35S-methionine -labeled proteins could be resolved 
by SOS-PAGE and five of them were clearly immunoprecipitated (Sundqvist et al., 
1990; Linne et al., 1992). The proteins that vary for the genera are non-structural 
proteins (C, 1 C or NS 1 ), a cystein-rich protein V, a small integral membrane protein 
------ - --- - -- - - --- - ---- ---
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SH or 1 A and a second inner envelope unglycosylated protein M2 (Lamb and 
Kolakofsky., 1996). 
Nucleocapsid Protein (NP) 
The structure-function relationships of the NP of the Paramyxoviridae have 
been deduced based on the studies of NP of various member viruses (Lamb and 
Kolakofsky, 1996). A large number of (26,000) sub-units of NP is associated with 
the single stranded RNA genome of the paramyxoviruses (Heggeness et al., 1980; 
Egelman et al., 1989). The arrangement of the NP sub-units on the RNA serves to 
confer helical symmetry on the ribonucleoprotein by producing a hollow core which 
forms an internal helical groove (Egelman et al., 1989; Heggenes et al., 1980; Nagai 
et al., 1989). NP is considered to be part of the template for RNA synthesis 
(Hamaguchi et al., 1983). During replication the NP assembles the nascent anti-
genome (Blumberg et al., 1981 ). The RNA within the nucleocapsid is resistant to 
RNase at any salt concentration because it is protected by the surrounding NP 
(Kingsbury and Darlington, 1968; Heggeness et al., 1981 ). 
From the comparisons of sequences of many paramyxoviruses coupled with 
protease studies, two domains have been suggested for the NP, the N-terminal 80% 
of the protein which is relatively conserved among related viruses and the C-terminal 
20% which is poorly conserved (Rozenblatt et al., 1985). Curran et al. (1993) found 
for the Sendai virus that the hypervariable C-terminal tail of NP is required for 
genome synthesis in vivo but not in vitro. 
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A comparison of the amino acid sequence of the NP of ten paramyxoviruses 
indicates a region of high sequence identity near the middle of the protein and a C-
terminal region which is enriched in negatively charged residues (Parks et al., 1992). 
The molecular weight of the NP varies within the paramyxoviruses, 56,534 for simian 
virus 5; 62,000 for sendai virus; and 68,000 for LPMV (Curran et al., 1993; Parks et 
al., 1992; Sundqvist et al., 1990). 
Phosphoprotein P 
The P proteins of the paramyxovirus family are highly phosphorylated 
(Chambers and Samson, 1980; Sundqvist et al., 1990) and they vary in length 
amongst the virus members of the family. The P protein of the parainfluenzaviruses 
and morbiliviruses are 507 to 603 amino acids long, that for the rubulaviruses are 
245 to 397 residues long while that for the pneumoviruses are 241 residues long 
(Bellini et al., 1985; Lamb and Kolakofsky, 1996). The P protein is important for 
RNA synthesis (Deshpande et al., 1985; Hamaguchi et al., 1983; Horikami et al., 
1992). The P protein is also needed for the formation of the NP-P complex required 
for the replication of both defective interfering particles and the formation of 
intracellular nucleocapsids (Horikami et al., 1992). 
Both P and L proteins are required to form a fully active transcription complex 
with a functional template (Hamaguchi et al., 1983). In addition, P and L must be co-
expressed for biological activity. Two protein complexes NP-P and P-L are required 
for nucleocapsid RNA replication. The P-L complex serves as the RNA polymerase 
and the NP-P is required for the encapsidation of the newly synthesized RNA 
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(Curran et al., 1994; Hamaguchi et al., 1983; Horikami et al., 1992). The vesicular 
stomatitis virus (VSV) phosphorylated protein NS which is the possible analogue of 
P protein regulates the direct role that the N protein plays in VSV genome replication 
(Masters and Banerjee, 1988). This is done by formation of the N-NS complex 
which specifically binds the nascent VSV genome or anti-genome (Masters and 
Banerjee, 1988). Similarly, the P protein is thought to form the NP-P complex to 
prevent NP from binding RNA non-specifically (Nagai et al., 1989; Lamb and 
Kolakofsky, 1996). 
The paramyxovirus P gene is transcribed into a single mRNA that is read in 
two or three independently initiated reading frames, one coding for the P protein, the 
second for the smaller C protein (Bellini et al., 1985), and the third for the V protein 
which is present only in the LPMV (Berg et al., 1992; Linne et al., 1992; Patterson 
and Lamb, 1990). Curran et al. (1993) noted that for the Sendai virus and vesicular 
stomatitis virus, the P gene appears to be a modular protein which has a template 
binding domain with the C-terminal amino acids 345-412 and 479-568 (Ryan and 
Portner, 1990) and a separate independently acting acidic "activation" domain with 
residues 1-77 of the N-terminus. The large regions of the protein between the two 
proteins can be deleted with only moderate loss of activity. The phosphorylated 
sites of P are concentrated in the N-terminal half (Curran and Kolakofsky, 1990). 
C Protein 
The C protein is a nonstructural protein that is detected only in infected cells 
and its function is unknown (Lamb and Choppin, 1977a). The C protein of the 
--- - - -- -- -- --- --~- -------------
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Sendai virus has been shown to be synthesized in several different types of cells 
infected with the same strain of Sendai virus but not in uninfected cells (Lamb et al., 
1976; Lamb & Choppin, 1977b). In support of this, Etkind et al. (1980) found strain 
specific differences in electrophoretic mobility of the C polypeptide synthesized in 
the same host cells infected with different strains of Sendai virus. An additional 
polypeptide C 1 was found to be another form of C by peptide mapping (Etkind et al., 
1980). Polypeptides analogous to the C protein of Sendai virus have been found in 
several paramyxoviruses. 
The use of a variable number of in-phase start codons, including ACG and 
AUG codons to initiate this protein gives rise to the diversity of the C polypeptide 
(Boeck et al., 1992). The number of C related proteins expressed from the P genes 
varies for each virus: four for Sendai virus (C, C1, Y1 and Y2 ), two or three for the 
human parainfluenza virus-1 (HPIV-1 ), and one for human PIV-3 (Lamb and 
Kolakofsky, 1996). 
V Protein 
The P gene mRNAs, except for those of the pneumovirus, are co-
transcriptionally edited to form the V protein (Lamb and Kolakofsky, 1996). The 
mRNAs for the V protein contain a single additional G residue which creates an 
additional open reading frame (Wardrob and Bridis, 1991 ). For the measles virus, 
the V gene was shown to bind zinc (Liston and Bried is, 1994 ), however, the function 
of Vis not clear (Lamb and Kolakofsky, 1996). V protein, like the P protein, was 
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found to be highly phosphorylated and it was not found in virions (Curran et al. , 
1991 ). 
M Protein 
The matrix protein (M) is the most abundant protein in the paramyxovirus 
virion (Lamb and Kolakofsky, 1996). Studies have shown that the Sendai virus M 
protein exists in sub-units of 6 nm in diameter that are able to form filamentous 
aggregates which wind around one another to form a helical structure. It has been 
suggested that these filaments may be a form of the protein in virions (Hewit and 
Nermut, 1973). The M protein is important in viral assembly. There is the need for 
the M protein to be recruited at the perinuclear membranes by the nucleocapsid to 
participate in viral assembly and budding (Stricker et al., 1994). The M protein is 
thought to mediate the recognition between the nucleocapsid and the envelope 
glycoproteins (Portner and Murti, 1986). This M and glycoprotein interaction is 
important for virus assembly (Yoshida et al. , 1986a). The M protein is 
phosphorylated and incorporated only into plasma membranes that already contain 
viral glycoproteins (Nagai et al., 1976; Sanderson et al. , 1993). The M proteins are 
basic proteins with net charge at neutral pH of +14 to +17 and they are slightly 
hydrophobic (Lamb and Kolakofsky, 1996). 
Fusion (F) Glycoprotein 
The major function of the fusion (F) protein of paramyxoviruses is the fusion 
of viral envelope with host cell plasma membrane to allow the penetration of the 
virus into the host cell (Lamb and Kolakofsky, 1996). In the naturally synthesized 
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form, the fusion protein occurs as an inactive precursor F0 • It is cleaved by host cell 
proteases to form the active F1 and F2 proteins. The measles virus precursor was 
experimentally expressed and found to be cleaved into F1 and F2 and was able to 
induce syncytia formation and hemolysis of monkey erythrocytes (Alkhatib et al., 
1990). The cleavage of Fa creates a hydrophobic N-terminus in F1 that is conserved 
among paramyxoviruses. Novick and Hoestra, (1988) used hydrophobic 
photoaffinity labeling to label Sendai virus proteins during fusion with liposomes and 
demonstrated that hydrophobic interaction of the fusion protein with the target 
bilayer is an essential event in the fusion mechanism of viral membranes (Hsu et al., 
1983). Glycosylation is suggested to play an important role in the cleavage-
dependent activation of the precursor F0 protein or in its transport to subcellular 
regions where proteolytic cleavage occurs (Alkhatib et al., 1990). The N-terminal 20 
residues of the F1 proteins are extensively hydrophobic and highly conserved among 
F proteins of paramyxoviruses (Lamb and Kolakofsky, 1996). By use of co-
expression of recombinant fusion (F) and hemagglutinin-neuraminidase (HN) 
glycoproteins of paramyxovirus simian virus 5, it was found that syncytia formation is 
enhanced when F is co-expressed with homotypic HN protein (Horvath et al., 1992). 
The F protein gene of the porcine rubulavirus LPMV is similar to the F proteins of 
other paramyxoviruses but lacks the small hydrophobic protein sequence between 
the F and HN genes found in SVS and mumps viruses (Berg et al., 1997) 
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Hemagglutinin-Neuraminidase (HN) Protein 
The HN protein is responsible for the attachment of the virus to sialic acid 
which is the paramyxovirus receptor and it also mediates the enzymatic cleavage of 
sialic acid from the surface of virions and the surface of infected cells (Lamb and 
Kolakofsky, 1996). The HN of members of the genus paramyxovirus have both 
hemagglutinin (HA) and neuraminidase (NA) activities, the genus morbillivirus lacks 
NA and the pneumovirus lacks both HA and NA (Rima et. al., 1996). The HN of 
many paramyxoviruses has fusion-promoting activity and in simian virus 5 there is 
enhancement of fusion if F and HN proteins are co-expressed (Horvath et al., 1992). 
Proteolytic processing of HN is not common but some strains of Newcastle disease 
virus have been shown to have a larger precursor HN0 which is cleaved to 
biologically active HN (Nagai et al., 1989). 
L Protein 
The genome of all the non-segmented negative strand viruses contains an L 
gene encoding a large polypeptide of - 200 KO (Nagai et al., 1989). The L protein is 
the least abundant of the structural proteins. Both L and P proteins are required for 
the paramyxovirus RNA synthesis (Hamaguchi et al., 1983; Portner et al., 1988). L 
and P proteins associate with the nucleocapsid to form an active transcriptive 
complex (Hamaguchi et al., 1983; Portner et al., 1988). Roux and Kolakofsky (1974) 
found a protein kinase activity associated with the Sendai virus virions. The L 
protein of Sendai virus was shown to possess this protein kinase activity that 
catalyzes the phosphorylation of indigenous polypeptides (Lamb, 1975). 
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Paramyxovirus replication 
The members of Paramyxoviridae can replicate in enucleated cells and also 
their mRNA synthesis is insensitive to actinomycin D (Lamb and Kolakofsky, 1996). 
The entry of enveloped viruses into cells occurs by at least two general routes: the 
recognition of specific cell surface receptors and membrane fusion. Gangliosides 
and asialoglycoproteins serve as receptors for paramyxoviruses and rubulaviruses 
(Markwell et al., 1985 and 1986). The cell surface protein CD46 serves as the 
receptor for the morbillivirus and measles virus. No cellular receptor has been 
identified for the pneumoviruses. The adsorption of the virus to the cellular receptor 
is followed by the fusion of the viral membrane with the cellular plasma membrane at 
the neutral pH at the cell surface resulting in the release of the helical nucleocapsid 
into the cytoplasm. 
Transcription and genome replication 
Transcription is the first process in the replication of any negative strand RNA 
virus and it results in the synthesis of RNA. As the eukaryotes do not contain RNA-
dependent RNA polymerases, the virus codes for its own polymerase which is 
packaged into the virions (Nagai et al., 1989). The Sendai virus, Newcastle disease 
virus and vesicular stomatitis virus particles have been shown to contain an enzyme 
which catalyzes the incorporation of ribonucleotides into ribonucleic acid (RNA) 
(Stone et al., 1971; Huang et al., 1971 ). This enzyme is a single-stranded RNA 
which is complementary in base sequence to virion RNA (Stone et al., 1971 ). After 
fusion of the viral envelope with the host cell plasma membrane, the nucleocapsids 
------- ~------ -- -- - - - ----- - -- -
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enter the cytoplasm carrying multiple copies of the P/L polymerase. The 
polymerases bind the(-) genome template only at its 3. end (Lamb and Kolakofsky, 
1996). P molecules occur in 4 to 10 discrete clusters at varying locations along the 
length of the nucleocapsid in the cytosol while P molecules are uniformly distributed 
over the entire length of the nucleocapisd in the virion. This indicates the 
dependence of the distribution of P on the functional state of the nucleocapsid 
(Portner and Murti, 1986). RNA synthesis starts as soon as the genome encounters 
the ribonucleoside triphosphate in the cytoplasm with the synthesis of the ( +) leader 
RNA. Leader sequences are important in control of viral genome expression. They 
are about 50 nucleotides long with the first 12 nucleotides identical with the viruses 
of each genus and are well conserved across the sub-family Paramyxovirinae. The 
remainder of the leader sequence is U and A rich (Lamb and Kolakofsky, 1996). 
The virus promoters in the Paramyxoviridae family are always turned "on" and 
the viral polymerases are specific to virus templates. During transcription, the 
polymerase terminates at the end of the ( +) leader region and reinitiates at the 
beginning of the first gene. Re-initiation defines the polymerase that transcribes the 
template to make mRNA as opposed to the one that replicates the genome (Iverson 
and Rose, 1981; Castaneda and Wong, 1990). Re-initiation leads to a transcript 
which is capped at the 5' end and whose internal sequence can be co-
transcriptionally edited by G insertions at specific sites and at specific frequencies. 
The mRNAs are polyadenylated at the 3 · end. The polyadenylation of these viral 
RNAs is suggested to be due to reiterative copying of the stretch of four to seven U 
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residues on the template (Gupta and Kingsbury, 1982; Iverson and Rose, 1981; 
Robertson et al., 1981 ). 
The length of the poly (A) tail (-200 residues) is thought to be limited by chain 
termination. The polymerase skips the intergenic region, which is exactly 3 
nucleotides for paramyxovirus and morbillivirus and 1-56 nucleotides for the 
rubulaviruses and pneumovirus, in order to reinitiate mRNA synthesis at the next 
start sequence until it completes the L mRNA (Lamb and Kolakofsky, 1996). 
Several mechanisms of attenuation of gene expression at the transcriptional level by 
which paramyxoviruses can fine-tune the relative amounts of their mRNAs have 
been noted (Lamb and Kolakofsky, 1996). The frequency with which the 
polymerase restarts mRNA synthesis at each junction is high but decreases 
downstream which creates a gradient of mRNA abundance according to the position 
of the gene relative to the 3 - end of the template (Cattaneo et al., 1987). 
Hamman et al. (1990) observed a disparity at the M-F and HN-L boundaries 
for the Sendai virus. Another mechanism involves inefficient transcriptional 
termination and polyadenylation by which some viruses read through some junctions 
at higher frequency than usual and produce bicistronic mRNAs as noted for the 
pneumovirus, and the respiratory syncytial viruses that the start sequence of their L 
gene is situated upstream within the preceding M gene (Collins et al. , 1987). 
Attenuation of gene expression by biased hypermutation has also been described 
for the measles virus matrix gene in which U residues were changed to C (Bass and 
Weintraub, 1988; Cattaneo et al. , 1988). 
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Genome replication 
After translation of the primary transcripts and accumulation of viral proteins, 
anti-genome synthesis begins. The polymerase involved in the mRNA synthesis 
copies the same template without termination and re-initiation at the junctions. The 
nucleocapsid protein (NP) has been shown to be responsible for the read through for 
the vesicular stomatitis virus polymerase (Perault et al., 1983). For VSV, it is 
proposed that when the newly synthesized N proteins attach to the nascent 
replicating plus leader RNA and encapsidate it, the RNA polymerase reads through 
boundaries between the leader and the N genes. In the presence of N, this read-
through may occur successively throughout the template until full-length plus sense 
nucleocapsid is formed. The full length plus strand copy of the genome RNA serves 
as the template for progeny virus(-) RNA. There are no re-initiation sites on the 
anti-genome template and so termination of the (-) leader RNA serves only to 
recycle the polymerase (Lamb and Kolakofsky, 1996). 
Calain and Roux (1993) observed that for the Sendai virus RNA to serve as a 
proper template for efficient replication, the RNA must contain a total number of 
nucleotides that is a multiple of six. This was interpreted as a requirement for the 
nucleocapsid protein to contact exactly six nucleotides (Calani and Roux, 1993). 
The Sendai virus, which is a parainfluenza virus type 1, contains a RNA 
genome which is specific to the virus-specific mRNAs found in infected cells 
(Kingsbury et al., 1978; Kolakofsky and Bruschi, 1975). Defective interfering 
genomes result from replicative errors of the activities of the polymerase creating 
internal deletions, or by creation of an inverted repeat (Re et al., 1983). The 
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defective-interfering genomes are thought to interfere with non-defective helper virus 
because they have a competitive advantage (Lamb and Kolakofsky, 1996). They 
have also been implicated in establishing permanent infections (Calain and Roux, 
1988). 
Virus assembly 
The cytoplasm is the site of synthesis of the nucleocapsid. The Sendai virus 
nucleocapsid assembly occurs in two steps. First, the free NP sub-units associate 
with the viral genome RNA to form the helical RNP structure and, next, the P-L 
protein complex associates with the viral genome (Kingsbury et al., 1978). The 
assembly of the envelope takes place at the cell surface. The viral integral 
membrane proteins are synthesized in the endoplasmic reticulum and undergo a 
stepwise conformational maturation before transport through the secretory pathway 
(Lamb and Kolakofsky, 1996). The virus particles are assembled at the plasma 
membrane (Stricker et al., 1994; Lamb and Kolakofsky, 1996). The M protein is 
required to interact with the nucleocapsid at the perinuclear membranes to 
participate in viral assembly and budding (Stricker et al., 1994). Glycoprotein 
cytoplasmic tails make important contacts with the M protein which, in turn, 
associates with the nucleocapsid (Lamb and Kolakofsky, 1996). 
Pathogenesis 
Viral pathogenesis involves a complex interaction between the virus and the 
host. Infection of the host is a prerequisite to disease production. Availability of a 
large number of strains with variable virulence facilitates understanding of 
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mechanisms of virulence (Nagai et al., 1989). The Sendai virus has been used as a 
model to understand mechanism of pathogenicity of paramyxoviruses. Sendai virus 
infection is localized to the respiratory organs in the natural host. The Sendai virus 
H0 protein has a single basic residue at the cleavage site and it is activated in 
limited types of tissues (Homann et al., 1990). The spread of virus in the lungs is 
due to the presence of an appropriate cleaving enzyme which resembles trypsin. 
Limited information is available on the pathogenicity of porcine paramyxovirus 
(PPMV) isolate ISU-92. Inoculation of six-week old specific pathogen free (SPF) 
pigs with cell-free cultures of lung homogenates did not produce clinical illness 
although all the inoculated pigs developed antibody titers to ISU-92 (Janke et., 
1992). In another study, inoculation of three day-old SPF pigs with cell culture 
propagated PPMV, resulted in clinical illness characterized by slightly elevated body 
temperature for 24 hours, mild diarrhea and dyspnea. Evidence of pneumonia with 
ten to fifteen percent lung involvement was detected in inoculated pigs (Battrell, 
1995). The alveolar walls were irregularly thickened by reactive hypertrophy and 
proliferation of alveolar pneumocytes and by infiltration of macrophages. The 
inflammation varied in severity from lobule to lobule. In some lobules alveolar and 
bronchiolar lumens contained clusters of sloughed pneumocytes and infiltrating 
leukocytes. The epithelium that lined terminal bronchioles appeared slightly 
hyperplastic. In one pig glial nodules were observed in the brain. All the subjects 
developed antibody titers to the paramyxo-like virus (Janke et al., 1992). 
Another paramyxovirus, referred to as LPMV for Le Piedad Michoacan virus, 
has been isolated in Mexico (Moreno-Lopez et al., 1986; Stephano et al., 1988). The 
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La Piedad Michoacan virus was isolated from the brain of a piglet with a disease 
associated with encephalitis, reproductive failure and corneal opacity in 1986 
(Stephano et al., 1988). The LPMV is a member of the family Paramyxoviridae 
isolated in pigs and has been characterized as a Rubulavirus (Moreno-Lopez et al. , 
1986; Rima et al., 1996). LPMV has been found to grow in many cell cultures 
producing cytopathic effects in the form of syncytia formation and cytopathic 
inclusion bodies. Hemagglutination, neuraminidase and hemolytic activities have 
also been observed for the LPMV (Moreno-Lopez et al., 1986). The natural infection 
of LPMV in pigs is presumed to be acquired by inhalation. The clinical signs of the 
disease caused by LPMV vary according to the age of the pig. Piglets 2-15 days old 
are the most susceptible and show a sudden onset of clinical signs. In the 2-15 
days old group, the clinical signs include prostration, depression, and nervous signs. 
There occurs also fever, a staring coat and an arched back sometimes accompanied 
by constipation or diarrhea, followed by progressive nervous signs (ataxia, 
weakness, rigidity mainly of the hind legs, muscle tremors and abnormal posture). 
Other signs include anorexia only in the immobilized piglets, conjuntivitis with 
swollen eyes and lacrymation, unilateral or bilateral corneal opacity in 1-10% of 
infected piglets. Death of piglets occurs 48 hours after the appearance of clinical 
signs in the first cases observed and 4-6 days in later cases (Stephano et al., 1988). 
lnfectivity is 20-65% in litters farrowed during outbreaks and the morbidity of 
infected litters is 20-50% with a mortality of 87-90%. Piglet mortality lasts from 2-9 
weeks. Most sows from affected litters appear clinically normal. Moderate anorexia 
in sows one or two days before the appearance of clinical signs in piglets may be 
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observed. Corneal opacity occurs in some sows in the farrowing houses during 
outbreaks. Abortions in some dams have been observed and number of stillborn 
and mummified fetuses increases during outbreaks (Stephano et al., 1988) 
In weaned piglets, older than 30 days, moderate and transient clinical signs 
(anorexia, fever, sneezing and coughing) occur. Nervous signs are rare and include 
depression, ataxia, circling and swaying of the head. In this group, corneal opacity 
and conjunctivitis are observed without other signs and continue to appear for 
another month (Stephano et al., 1988). Clinical signs and lesions similar to those 
observed in natural infections have been reproduced in one-day old piglets by 
experimental intracerebral, intratracheal and intranasal inoculation with isolated 
LPMV (Stephano et al., 1988). Experimental inoculation of boars with LPMV has 
demonstrated that severe epididymo-orchitis and reduced semen quality in sexually 
matured boars can result from LPMV infections (Ramirez-Mendoza et al., 1997). 
The disease has also been reproduced by contact with experimentally infected 
animals (Stephano, 1988). 
The nasal mucosa has been suggested as the initial site of replication of the 
LPMV from where it spreads early in the infection to the brain and lungs. The 
interstitial pneumonia observed suggests dissemination through the blood. Corneal 
opacity which usually occurs late in the course of the disease is thought to be due to 
an immunologic reaction similar to that produced by canine adenovirus. There are 
also indications that the virus replicates in the cornea (Stephano, 1992). The virus 
reaches the uterus through the blood resulting in embryonic mortality, stillbirths and 
mummified fetuses in pregnant sows (Stephano, 1992). 
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An apparently new paramyxovirus was isolated from pigs in Australia and it 
was found to infect humans (Philbey et al., 1998). It was suggested that bats may 
be involved in the ecology of this Australian porcine paramyxovirus (Chant et al., 
1998). 
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CHAPTER 2. VIRAL ULTRASTRUCTURE AND 
SEQUENCING OF THE P GENE OF THE PORCINE PARAMYXO-LIKE VIRUS, 
ISU-92 
A paper to be submitted to the Archives of Virology 
Peter K. B. Akoto, Igor Morozov, Susan Schommer, Patrick G. Halbur, 
Bruce H. Janke, and Prem S. Paul 
Abstract 
The ISU-92 strain of porcine paramyxo-like virus isolated from pigs 
with neurological and respiratory disease was morphologically and ultrastructurally 
characterized. Electron microscopic examination of gradient purified virus and 
nucleocapsids revealed variable forms of the pleomorphic PPMV virions with a 
diameter of 150-400 nm for spherical virions and the serrated nature of the 
nucleocapsids. Comparison of the morphological and antigenic data with those of 
other paramyxoviruses suggested that ISU-92 is a true and unique paramyxovirus. 
A random primed cDNA library was prepared in lambda vector from 
polyadenylated mRNA from vero cells infected with porcine paramyxovirus strain 
ISU-92. A virus-specific probe prepared by subtractive hybridization of 32P labeled 
cDNA from virus infected vero cells was used to screen the cDNA library. One virus-
specific clone containing an insert of 1962 base pairs was sequenced and shown to 
contain the reverse transcript of the mRNA coding for the P gene. The coding 
sequence (ORF) started at position 52 (ATG included) and ended at position 1839 
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(stop codon not included) of this clone. The mRNA was 1962 nucleotides long 
followed by a poly-A tail. The total length of the gene was 1788 nucleotides and it 
encoded a protein of 596 amino acids. The sequence of the mRNA was compared 
with the genome of BPIV-3 (15,548 nucleotides and corresponds to the region of 
BPIV-3 genome from 1732 to 3699 nucleotides with an overall homology of 98%. 
This study shows that PPMV, ISU-92, is closely related to bovine parainfluenza virus 
3 and human parainfluenza virus 3. 
Introduction 
In recent years, several paramyxoviruses have been reported in different 
animal species (Greig, 1971; Lipkind 1986; Moreno-Lopez 1986; Philbey et al., 1998; 
Richter et al., 1996). A viral agent was isolated in 1992 in the United States 
(Minnesota) from a disease outbreak in pigs characterized by central nervous 
system (CNS) and respiratory disorders (Janke et al., 1992). This, previously 
uncharacterized virus was designated as ISU-92 and called porcine paramyxo-like 
virus based on preliminary antigenic studies (Janke et al., 1992). Battrell et al., 
(1993) further characterized the virus and termed it porcine paramyxovirus (PPMV). 
Previous studies of this virus have shown that it cross-reacts antigenically with 
antibodies against PIV-1, PIV-3 and PIV-48 but not with antibodies against La 
Piedad Michoacan virus (LPMV) (Janke et al., 1992). The evidence suggested that 
the virus belongs to the Family Paramyxoviridae (Janke et al., 1992; Battrell, 1995) 
but detailed characterization needs to be done. 
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Few cases of paramyxoviruses in pigs have been reported (Brun et al., 1992; 
Chang-GuoQuan and Chang, 1996; Greig et al., 1971; Lipkind et al., 1986; Moreno-
Lopez et al., 1986; Philbey et al., 1998). A fatal disease outbreak of pigs was first 
reported in Mexico in 1981. The La Piedad Michoacan virus (LPMV) was isolated 
from pigs with a disease which was characterized by encephalitis, reproductive 
failure and corneal opacity (Moreno-Lopez et al., 1986; Stephano et al., 1988). 
Another porcine paramyxovirus was isolated from the lungs of a pig in Northrhine 
Westphalia in Germany by Brun et al., (1992). This German strain of porcine 
paramyxovirus showed no antigenic cross-reactivity with the Mexican LPMV 
(Groschup et al., 1993). An apparently new paramyxovirus was isolated from pigs in 
Australia and it was found to infect humans (Philbey et al., 1998). It was suggested 
that bats may be involved in the ecology of this Australian porcine paramyxovirus 
(Chant et al., 1998). 
The virions of the paramyxoviruses are mostly spherical with other 
pleomorphic forms with a diameter of 150-500nm (Plowright, 1962, cited in Lamb 
and Kolakofsky, 1996). The genomes of the paramyxoviruses are single-stranded, 
non-segmented RNA of negative polarity (Hilleman et al., 1962). The six genes of 
the paramyxoviruses code for structural proteins (Sakai et al. 1987) and are ordered 
as 3, leader, NP (or N), P, M, F, HN, L, 5' (Elango et al., 1988; Linne et al., 1992; 
Sakai et al., 1987; Sanchez and Banerjee, 1985). The paramyxovirus virion 
contains a nucleocapsid which is made up of genomic RNA. Three proteins NP, P 
and L are associated with the nucleocapsids and contribute to the characteristic 
helical structure of the nucleocapsids (Oglesbee et al., 1989). 
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There is limited information available on the biology and molecular biology of 
PPMV. In this study, we report the results of the electronmicroscopic examination of 
purified virions and nucleocapsids and the cloning and sequencing of the P gene of 
the PPMV. 
Materials and Methods 
Virus and cells 
Vero cells grown in minimal essential medium (MEM) (Gibco) containing 10% 
fetal bovine serum (FBS) and antibiotics (500U/ml penicillin, 500 U/ml streptomycin 
and 1.25 mg/ml of amphotericin B) were used for the cultivation of the virus. The 
virus used for the study was the porcine paramyxo-like virus, ISU-92, isolated from 
pigs with naturally occurring neurological and respiratory disease (Janke et al., 
1992). The virus had been plaque purified three times and was stored at -80°C. 
The growth medium was removed from four-day old monolayers of vero cells grown 
in 75 cm2 tissue culture flasks. Cells were inoculated with PPMV at a multiplicity of 
infection (m.o.i.) of 0.5 PFU/cell. The cells were incubated at 37°C for 2 hours and 7 
ml of MEM containing 2% FBS and antibiotics were added. The cells were further 
incubated until 75% of cells showed cytopathic effect (CPE). 
The flasks of cells were frozen-thawed three times, and the contents pooled 
and clarified at 1,000xg for 10 minutes. This supernatant was stored at -80°C as 
the virus stock and titrated by plaque assay. A serial dilution (10-1 to 10-10) of the 
virus was made in MEM. Four-day old monolayers in six-well plates were inoculated 
with 0.2 ml/well of each of the serial dilutions of the virus. The cells were incubated 
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for 1 hour and the inoculum was removed and 2 ml of agar overlay (50:50 BME and 
2% sea plaque agar containing phenol red and 7 .5% NaHC03) was added per well. 
The cells were incubated for 5 days and a plaque count was made to calculate the 
titer. 
Virus propagation and purification 
The virus was propagated in large quantity and the supernatants were 
collected at 30-4B hours post infection and frozen at -B0°C. Three to four day-old 
vero cells were infected with PPMV at a m.o.i of 0.5 PFU/cell prepared in MEM 
without FBS in a final of 3 ml per flask. The flasks were incubated at 37°C for 1 hour 
with the tilting of the flasks every 15 minutes to distribute the inoculum over the cell 
layers. After 1 hour incubation, 10 ml of MEM containing 2% FBS, antibiotics and an 
antimycotic solution were added to each flask. The flasks were incubated at 37°C 
until extensive fusion of cells and syncytia formation (about BO%) was observed. The 
supernatants were then collected, frozen and thawed once at -B0°C. The 
supernatants were clarified at 1 OOOxg for 10 minutes or 1 O,OOOxg for 10 minutes and 
layered onto a 20% sucrose cushion. The virus was concentrated into pellets at 
100,000xg for 4 hours in SW2B rotor (Beckman). The virus was purified by sucrose 
gradient centrifugation. The virus pellets were re-suspended in TEN (10 mM Tris-
HCI, 1 mM EDTA, 0.1 M NaCl) buffer (pH B.O) and layered onto a 10-60% sucrose 
gradient prepared in water and centrifuged at 170,000xg for 2 hours in a SW41 rotor 
(Beckman). The virus containing bands were collected and diluted in TEN buffer 
(pH 8.0). The partially purified virus was pelleted at 100,000xg for 4 hours. The 
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pellets were re-suspended in TEN buffer (pH 8.0) and stored at -80°C or re-
suspended in water for immediate use. When necessary, two more sucrose 
gradient centrifugations were performed to further purify the virus. 
Isolation of nucleocapsids (NC) 
Nucleocapsids were isolated by the method described by Kolakofsky (1976). 
Four day-old monolayers of vero cells were infected at a high m.o.i. of 0.5 PFU/cell 
as described earlier. At 24-30 hours post infection, when the CPE was about 60-
80%, the media was removed from the cells and the monolayers washed twice with 
5 ml of normal saline (4°C). The cells were lysed as described by Maniatis et al. 
(1989) by addition of 2 ml of 0.6% NP40 lysis buffer, per 75 cm3 tissue culture flask 
of infected cells. The flasks were incubated on a flat bed of ice for 20 minutes. A 
plastic cell scraper was used to scrape the lysed cells and the cell lysate was 
pipetted into a 35 ml centrifuge tube. The cell lysate was mixed vigorously on a 
stirrer and put on ice for 5 minutes. Cellular nuclei and membranes were removed 
by centrifugation at 1 O,OOOxg (Kolakofsky, 1976). A discontinuous cesium chloride 
gradient was prepared in 14x89 mm ultracentrifuge tubes from 3.0 ml of 5% (1.176 
g/ml) sucrose, 2.6 ml of 25% (1.2255 g/ml) CsCl2, 2.6 ml of 30% (1.2858 g/ml) CsCl2 
and 1.4 ml of 40% (1.4196 g/ml) CsCl2. A 0.5-0.7 ml of cell lysate was layered onto 
the gradients and centrifuged using a SW41 rotor (Beckman) at 170,000xg for 2 
hours at 4°C. The distinct bands found at the 30/40% interphase were collected. 
The collected bands were diluted 4-5 times in TEN buffer (pH 8.0) and centrifuged to 
pellet the nucleocapsids using a SW28 rotor at 100,000xg for 4 hours at 4°C. The 
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pellets were washed three times with TEN buffer and re-suspended in TEN buffer. 
The purified nucleocapsids were stored at 4°C until used. 
Electron microscopy of virions and nucleocapsids 
Virions partially purified by sucrose gradient centrifugation and nucleocapsids 
purified by CsCl2 gradient centrifugation were prepared for electron microscopy in 
two ways. For each sample, 15 drops of distilled water were put in a well. Then two 
drops of 4% phosphotungstic acid (PTA), 1 drop of 0.5% bovine serum albumin 
(BSA) and 1 drop of each sample were added in that order to each well. The 
contents of each well were mixed gently with a Pasteur pipette. The mixture was 
applied to a carbon coated 200-mesh-grid with a nebulizer (Tel. Pella Inc., Tustin 
CA). The grids were then examined under the microscope (Hitachi H500) at 75KV. 
Alternatively, 5 µI of the samples were spotted onto the center of the carbon coated 
200-mesh grid and allowed to adsorb for 7-10 minutes. Excess sample was 
removed with a piece of filter paper. Next, 5 µI of the 3 % PT A were spotted onto the 
grid and the excess removed after 30 seconds. The grids were air-dried for 1 minute 
and examined under the electron microscope (Hitachi H500) at 75KV. 
Isolation of total RNA from vero cells infected with virus 
Total RNA was isolated using an RNA isolation kit and the procedure outlined 
for adherent cells grown in cell culture as indicated by the manufacturer (Stratagene, 
Loyola, CA). Four-day old vero cells in 75cm2 tissue culture flasks (x4) were 
infected at approximately 1.0 m.o.i/cell as described above and incubated for 15 
hours. The medium was replaced with 10.0 ml of MEM containing 2% FBS and 2 
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µg/ml of Actinomycin D. The cells were further incubated for 14 hours till CPE was 
extensive (80-100% ). 
The medium was removed from the cells and 4.0 ml of lysis solution D (100 µI 
~-mercaptoethanol in 14 ml of denaturing solution or 1%SDS) were added. The 
flask was swirled for 30 seconds and the cell lysate was transferred to the next flask 
and the procedure continued till the last flask. The pooled cell lysate was collected 
into a centrifuge tube. Then 0.4 ml of 2M sodium acetate and 4.0 ml of phenol 
saturated with water were added in order with gentle mixing. A 0.8 ml solution of 
chloroform:isoamyl alcohol was added and the contents of the tube were vigorously 
mixed for 10 seconds and placed on ice for 15 minutes. The mixture was 
centrifuged at 1 O,OOOxg for 5 minutes and the upper aqueous layer was transferred 
into new microcentrifuge tubes in aliquots of 500 µI. Equal volumes of isopropanol 
were added to the tubes, mixed and then put on dry ice for 10 minutes. The tubes 
were stored at-20°C overnight to precipitate the RNA. The RNA was pelleted at 
1 O,OOOxg for 15 minutes and washed with 70% ethanol: 25% diethyl pyrocarbonate 
(DEPC)-treated water. The pellets were vacuum-dried for 15 minutes and then re-
suspended in 20 µI DEPC-treated water. A 1 :60 dilution of the RNA was made in 
300 µI of water and the RNA concentration determined by spectrophotometry at 
00250. 
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cDNA synthesis 
The synthesis of the first and second strands of cDNA was performed with the 
cDNA synthesis kit according to the manufacturer's instructions (Uni-Zap, 
Stratagene, Loyola, CA) except for a few modifications. First strand synthesis was 
performed by reverse transcription of mRNA with a 50-base oligonucleotide linker 
primer (Zap-cDNA Synthesis Kit, Stratagene ). All of the non-enzymatic reagents of 
first strand synthesis were thawed, mixed, centrifuged and put on ice. The first 
strand reaction was set up by combining 5 µI of 1 OX first strand buffer, 3 µI of first 
strand 5'methyl nucleotide mix (normal dATP, dGTP, dTTP and 5-methyl dCTP), 
2 µI of linker primer (1.4 µg/ml), 35.5 µI of DEPC-treated water, 1.0 µI of 
ribonuclease inhibitor and 2 µI (-18.78 ng) of total RNA in the order listed and mixed 
gently. The primer was allowed to anneal to the template for 10 minutes at room 
temperature. The 1.5 µI of MMLV-RT (50 U/µI) was added to the first strand reaction 
to obtain a final reaction volume of 50 µI. The reaction sample was mixed gently, 
briefly centrifuged and incubated at 37°C for 1 hour. 
The second strand was synthesized by nicking the hybrid RNA bound to the 
first strand cDNA to produce a multitude of fragments which served as primers for 
DNA polymerase I to nick translate these RNA fragments into second strand cDNA. 
To ensure that the restriction sites in the linker primer remained susceptible to 
restriction enzyme digestion, the second strand nucleotide mixture was 
supplemented with dCTP to reduce the probability of 5-methyl dCTP becoming 
incorporated in the second strand. All of the non-enzymatic components of the 
38 
second strand were thawed, vigorously mixed, centrifuged and put on ice. The 
second strand components which included 20 µI of 1 OX second strand buffer, 6 µI of 
second strand dNTP mix (normal dATP, dGTP, dTTP and dCTP) and 116 µI of 
sterile water were added to the 50 µI of the first strand synthesis reaction on ice and 
mixed. In the order listed, 2 µI of RNase H (1.5 U/µI) and 11 µI of DNA polymerase I 
(9.0 U/µI) were added to the reaction. The contents of the tube were mixed and 
centrifuged in a microcentrifuge tube and incubated at 16°C for 2.5 hours after which 
they were immediately put on ice. 
Construction of plasmids 
A cDNA library was constructed in bacteriophage lambda Uni-Zap XR vector 
(Stratagene, Loyola, CA) using total mRNA from vero cells infected with the porcine 
paramyxo-like virus, ISU-92. The uneven termini of the double stranded cDNA were 
filled in with cloned pfu DNA polymerase and EcoRI adapters were ligated to the 
blunt ends. The second strand reaction was kept on ice and 23 µI of blunting dNTP 
mix and 2 µI of cloned pfu DNA polymerase (2.5 U/µI) were added. The contents of 
the tube were quickly mixed, and incubated at 72°C for exactly 30 minutes. The 
tube was removed from 72°C to room temperature and 200 µI of phenol:chloroform 
[1 :1 (v/v)] pH 7.8 was added and the contents mixed by agitation. The tubes were 
centrifuged at a 1 O,OOOxg for 2 minutes at room temperature and the upper aqueous 
layer containing the cDNA was transferred to a new tube. An equal volume of 
chloroform was added and mixed. 
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The reaction tube was centrifuged for 1 O,OOOxg at room temperature and the 
upper aqueous layer containing the cDNA was transferred to a new tube. The cDNA 
was precipitated overnight after adding 20 µI of 3M sodium acetate and 400 µI of 
100% (v/v) ethanol. The tubes were agitated and stored at -20°C overnight. The 
cDNA was pelleted in a microcentrifuge at 1 O,OOOxg for 60 minutes at 4°C. The 
supernatant was carefully discarded and the pellet washed by adding 500 µI of 75% 
(v/v) ethanol: 25% DEPC-treated water and centrifuged at maximum speed at room 
temperature for 2 minutes. The ethanol was pipetted out and the pellet was 
vacuum- dried for approximately 15 minutes until dry. The pellet was re-suspended 
in 9.0 µI of EcoRI adapters and incubated at 4°C for 30 minutes to allow the cDNA to 
re-suspend and the tube was put on ice. The EcoRI adapters of the sequence 
5, -OH-AA TTCGGCACGAG 3' 
3, GCCGTGCTC 5, 
were ligated to the termini-blunted cDNA. The tube containing the blunted cDNA 
and the EcoRI adapters were kept on ice and 1.0 µI of DNA 1 OX ligase buffer, 1.0 µI 
of 10 mM of rATP and 1.0 µI of T 4 DNA ligase (4 U/µI) were added. The tube was 
briefly centrifuged in a microcentrifuge and incubated at 8°C overnight. The T 4 DNA 
ligase was inactivated by heating at 70°C for 20 minutes. The reaction mix was 
briefly centrifuged for 2 seconds and cooled to room temperature for 5 minutes. 
The EcoRI ends were phosphorylated by adding 1.0 µI of 1 OX ligase buffer, 
2 µI of 10 mM rATP, 6 µI of sterile water, and 1 µI of T 4 polynucleotide kinase ( 1 O 
U/µI). The reaction was incubated for 30 minutes at 37°C and the kinase was heat 
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inactivated at 70°C for 30 minutes. The reaction was briefly centrifuged and allowed 
to equilibrate to room temperature for 5 minutes. Restriction digestion of cDNA with 
Xhol was performed to release the EcoRI adapter and the residual linker primer 
from the 3- end of the cDNA. A 28 µI of Xhol buffer supplement and 3 µI of Xhol (40 
U/µI) were added to the phosphorylated reaction . The reaction was incubated for 
1.5 hours at 37°C and 5 µI of 1 OX STE buffer and 125 µI of 100%(v/v) ethanol were 
added . The cDNA was precipitated overnight at-20°C and pelleted in a 
microcentrifuge at 1 O,OOOxg for 60 minutes at 4°C. The pellet was vacuum dried, re-
suspended in 14 µI of 1X STE buffer and put on ice. 
After Xhol digestion the cDNA was size fractionated to select the size of DNA 
for cloning by running through a strip column containing Sepharose CL-28 gel 
filtration medium (Stratagene, Layola, CA) according to the manufacturer's 
instructions. 
Twelve fractions of three drops each were collected into separate 1 ml tubes. 
Starting from the first fraction, each of the three successive fractions were pooled 
together and cDNA extracted with phenol:chloroform and precipitated with ethanol. 
To each sample, 300 µI of phenol (pH 7.8): chloroform was added. The contents in 
the tubes were vigorously mixed and centrifuged in a microcentrifuge at 1 O,OOOxg for 
2 minutes. 
The upper aqueous layers were transferred to new tubes and an equal 
volume of chloroform added. The tubes were agitated vigorously and centrifuged at 
1 O,OOOxg for 2 minutes. The upper aqueous layers were transferred to new tubes 
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and 500 µI of 100% ethanol added. The tubes were stored at -20°C to precipitate 
the DNA. The cDNA was pelleted at 1 O,OOOxg in a microcentrifuge for 60 minutes, 
washed with 75% ethanol, vacuum dried 15 minutes and resuspened in 3.0 ml of 
sterile water. 
The DNA in the cDNA fractions was quantitated by the ethidium bromide 
assay. A 0.8% (w/v) agarose plate containing 0.001 µg/ml of ethidium bromide was 
prepared using Tris-Acetate-EDTA (TAE) buffer. A standard DNA sample of known 
concentration was serially diluted to obtain concentrations of 200 to 10 ng/ml and 0.5 
µI of each dilution was spotted onto the ethidium bromide plate. Then 0.5 µI of the 
DNA samples were spotted onto the plate adjacent to the standards. After 15 
minutes of adsorption of the spots, the plate was photographed using UV light. 
The spotted samples of unknown DNA concentration were compared with the 
standards. The cDNA fraction corresponding to the largest size DNA with a 
concentration of -37.5 ng/ml was ligated into the Uni Zap XR vector (Stratagene). 
Ligation was performed in a 5 µI volume reaction by adding together, 2µ1 of 
resuspended cDNA (-100 ng), 0.5 µI of ligase buffer, 0.5 µI of 10 mM rATP (pH 7.5), 
1.0 µI of the Uni-Zap XR vector (1 µg/µI), 0.5 µI of sterile water and 0.5 µI of T4 DNA 
ligase (4 U/µI). The reaction was incubated at 12°C for 24 hours. 
The recombinant lambda phage was used directly from the ligation reaction 
for packaging using the Gigapack II Gold 7 packaging extract (Stratagene, Loyola 
CA). The packaged lambda was briefly centrifuged and stored at 4°C until titration 
of the cDNA library. 
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Plating and titration of the cDNA library 
The cONA library was plated in XL 1-Blue MRF- cells to determine the titer 
and the ratio of recombinant plaques to the non-recombinant plaques by blue white 
color screening. The host bacteria, XL 1-Blue MRF-glycerol stock was streaked onto 
a pre-incubated LB-tetracycline agar plate and incubated overnight at 37°C. One 
colony was inoculated into 3 ml of LB broth supplemented with 10 mM of MgS04 and 
0.2% maltose and incubated overnight with agitation. The overnight culture (30 µI) 
was inoculated into 30 ml LB broth supplemented as above and incubated for 3 
hours with continuous agitation to obtain an 00600 -1.0. 
The bacterial cells were pelleted at 500xg for 10 minutes, resuspended in 1.2 
ml of 10 mM Mg S04 and placed at 4°C until used. The ligation product was plated 
by combining 1 µI of packaged reaction (cONA library) with 199 µI of XL 1-Blue 
MRF , cells (00500 - 1.0). Four serial dilutions of the mixture were made by the 
transfer of 20 µI mixture into 180 µI of XL 1-Blue MRF, cells. The tubes were 
incubated at 37°C to allow the phage to attach to the bacterial cells. Then 3 ml of 
top agar (melted and cooled to 50° C) was added to each dilution of the phage and 
plated immediately on NZY agar plates. After 10 minutes the plates were incubated 
at 37°C for 8 hours. 
Color selection with IPTG and X-gal was performed. A dilution of 1 µI of 
cONA library in 4 µI SM buffer was made. From the 1 :5 dilution of the phage, 1 µI 
was added to the 200 µI XL 1-Blue MRF, cells and incubated for 10 minutes at 37°C. 
The cells were mixed with 3 ml NZY top-agar (-50°C) to which 1 O µI of 0.839 M 
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IPTG and 50 µI of X-gal (250 mg/ml) had been added. The top agar was plated 
immediately on NZY agar plate and incubated at 37°C for overnight. 
Amplification of the Uni-Zap XR - cDNA library 
A single amplification of the cDNA library prepared in lambda Uni-Zap XR 
vector was performed. Four plating reactions were set in NZY agar plates (150 
mm). For each plate, 50 µI (-50x104 PFU) of the lambda library was mixed with 600 
µI of XL 1-Blue MRF' cells (ODsoo -1 .0) and incubated at 37°C for 8 hours. Then 10 
ml of SM buffer was added to each plate and the plates incubated at 4°C overnight 
with continuous agitation. The bacteriophage suspension was recovered and the 
plates were rinsed with an additional 2 ml of SM buffer. Chloroform was added to a 
final concentration of 5% (v/v) and the tubes were incubated for 15 minutes at 37°C. 
Cellular debris was removed by centrifugation at 500xg for 10 minutes and the 
clarified supernatant was divided into two aliquots. One portion of 22.5 ml was 
treated with 0.068 µI chloroform (final concentration 0.35%) and stored at 4°C. The 
second portion was aliquoted into 10 ml and 0.753 µI DMSO (final concentration 
0.7%) was added and stored at-80°C. The titer was determined as described 
earlier. 
Hybridization and screening 
Plaque lift was performed according to standard procedure by plating 10-
15,000 PFU of lambda phage per 150 mm plate. NZY agar plates were prepared in 
150 mm petri dishes and stored at 4°C for at least 2 days. A 1 O µI aliquot of the 
44 
library (-10-15,000 PFU) was mixed with 600 µI of XL 1-Blue MRF , cells (OD6o0-0.5) 
and plated on the NZY agar plates after 15 minutes incubation at 37°C. The plates 
were incubated at 37°C for 8 hours and placed at 4°C until plaques were lifted. 
Nitrocellulose membrane (Magna-nylon, Bio-Rad) was placed on the agar plates for 
2 minutes to allow the phage to transfer to the membrane and the orientation of the 
plates was marked by pricking through the agar with a needle. The nitrocellulose 
membranes were lifted and denatured by placing them on filter paper moistened in 
1.5 M NaOH denaturing solution for 2 minutes. The agar plates were returned to 
4°C. The membranes were neutralized for 5 minutes by transferring them to filter 
paper moistened in 1.5 M NaCl and 0.5 M Tris-HCI (pH 8.0) neutralizing solution. 
Membranes were transferred to filter paper moistened in 0.2 M Tris-HCI (pH 7.5) and 
2XSSC buffer rinsing solution for 30 seconds. The rinsed nitrocellulose membranes 
were blotted and air-dried on Whattman 3MM paper and baked for 15-30 minutes at 
80°C. 
A probe was prepared from viral mRNA and used to hybridize to plasmid DNA 
on membranes. Three-day-old monolayers of vero cells grown in 75 cm2 tissue 
culture flasks were infected at a m.o.i. of 1.0 PFU/cell as described earlier. At 15 
hours post infection, 20 µI of Actinomycin D was added to two flasks (final 
concentration 2 µg/ml). At 26 hours post infection when CPE was approximately 
100%, total RNA was isolated as described earlier and stored in ethanol at -20°C. 
Total RNA was similarly isolated from four 75 cm2 tissue culture flasks of uninfected 
two-day old monolayers of vero cells. The total RNA from the virus infected cells 
was reverse transcribed with AMV-RTase and randomly labeled with 32P in the 
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second strand synthesis reaction. Total RNA resuspended in 20 µI of DEPC-treated 
water was aliquoted into two 10 µI portions. To each 10 µI of RNA, 1 .5 µI of DEPC-
treated water and 1.0 µI of oligo d(T) primer (Stratagene cDNA synthesis kit) were 
added and heated at 65°C for 10 minutes. The tubes were incubated at room 
temperature for 2 minutes. The reverse transcription reaction components, 1 µI 
RNase inhibitor, 4 µI of 5X reverse transcription buffer, 1 µI of 100 mM dNTPs, 1 µI 
of 80 mM sodium pyrophosphate and 0.5 µI of AMV-RTase were added in the order 
listed. The reaction was incubated at 42°C for 60 minutes and denatured at 95°C for 
2 minutes. Phenol:chloroform extraction of cDNA was made. The reaction was 
treated in the order listed with 1 µI of 0.5M EDTA and 20 µI of phenol:chloroform. 
The tubes were vigorously agitated and centrifuged at 1 O,OOOxg for 3 minutes. The 
upper aqueous layer containing the cDNA was transferred to a new tube and 22 µI of 
ammonium acetate and 88 µI of 100% ethanol were added. The components were 
mixed and the tube placed at-80°C for 10 minutes and then transferred to -20°C to 
precipitate the cDNA overnight. The cDNA was pelleted at 1 O,OOOxg, vacuum dried, 
resuspended in 20 µI of water and used in random labeling reaction according to the 
multiprime DNA labeling system protocol (Amersham). Half of the cDNA resulting 
from one reverse transcription reaction was used for labeling. The 1 O µI of cDNA 
was denatured at 95°C for 3 minutes and immediately placed on ice. In the listed 
order, 10 µI of labeling buffer I, 5 µI random primers, 2.5 µI of a-32PdCTP, 20.5 µI of 
water and 2 µI of enzyme (Kienow polymerase I) were added. The contents of the 
tube were gently mixed and incubated at 37°C for 30-60minutes. The labeled cDNA 
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was denatured at 95°C for 3 minutes and immediately transferred onto ice. The 
cellular DNA in the labeled reaction was removed in a subtractive hybridization 
reaction to make the probe virus specific as described by Rozenblatt et al. (1985). 
Total RNA from uninfected and virus-infected vero cells was pelleted and 
resuspended in 20 µI of DEPC-treated water. These total RNAs were heated at 
65°C for 10 minutes and 2 µI of the virus infected and the uninfected cell RNAs were 
spotted per spot onto the nitrocellulose membrane (Zeta probe, Bio-rad) and baked 
for 15 minutes at 80°C for use as the control membrane for hybridization. The 
subtractive hybridization reaction was carried out by combining 50 µI labeled probe 
reaction, 125 µI prehybridization solution, 25 µI of RNA from uninfected cells and 
37 µI of denatured and sonicated salmon sperm DNA (final concentration, 150 
µg/ml). The reaction was incubated at 42°C for 4 hours. One hour prior to the 
completion of the subtractive hybridization reaction, the prehybridization of the 
spotted membrane and the plaque lift membranes was started. Approximately 100 
µI of prehybridization solution (50% formamide, 2X SSC buffer, 5X Denhardt, 0.1 % 
SOS and 100 µI denatured salmon sperm DNA) was added to the membranes and 
the reaction was incubated at 42°C for 60 minutes. 
Hybridization of the probe to the nucleic acids on membranes was performed 
by adding the subtractive hybridization reaction to the prehybridization reaction and 
hybridizing at 42°C for overnight (-12-16 hours). The membranes were rinsed twice 
with washing solution I (2XSSC and 0.1 % SOS). The cold wash solution I was 
replaced with 50 ml of washing solution I preheated to 60°C and the tubes were 
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incubated for 30 minutes at 60°C with continuous rotation. The first washing solution 
was replaced with washing solution II preheated to 60°C and membranes were 
similarly incubated at 60°C for 30 minutes. 
The membranes were prepared keeping them moist and exposed to X-ray 
films (X-Omat, Eastman KODAK, Rochester, NY) in separate cassettes. The 
cassettes were placed at -80°C for 48 hours and the films developed as per 
manufacturer's instructions. The X-ray film was aligned with the marks on the agar 
plates and the virus specific plaques were picked. Each positive plaque was placed 
into a mixture of 500 µI SM buffer and 20 µI chloroform. The tubes were vigorously 
mixed and incubated at room temperature for 2 hours and then placed at 4°C. A 
secondary screening of the picked plaques was performed as described above. 
In vivo single clone excision of pBluescript from the Uni-Zap XR vector 
The pBluescript (SK-) phagemid containing the inserts was subcloned from 
the Uni-Zap vector by an in vivo excision assay using the ExAssist helper phage as 
outlined by the manufacturer (Stratagene, Loyola, CA) with some modification. 
Single colonies of the XL 1-Blue MRF' and SOLR bacteria were separately 
inoculated into 3 ml of LB broth supplemented with 0.2% maltose and 1 OmM 
MgS04. The tubes were incubated overnight with continuous shaking in separate 
tubes and 300 µI of the overnight cultures were inoculated into 30 ml of LB broth 
(1: 100) and incubated for 3 hours with continuous agitation. The bacterial cells were 
pelleted at 1 ,OOOxg for 10 minutes and resuspended in 1.2 ml of 10 mM MgS04 to 
obtain an ODsoo -1.0. The cells were placed at 4°C until used. For the in vivo 
48 
excision reaction, 100 µI XL 1-Blue MRF (00600 -1 ), 100 µI phage stock and 1 µI of 
the ExAssist helper phage (>1x106 PFU/µI) were combined in Falcon 2059 tubes 
and incubated at 37°C for 15 minutes. A 3 ml of LB-broth was added to each tube 
and incubated at 37°C for 3 hours with continuous agitation. The tubes were heated 
in a water bath at 65-70°C for 20 minutes and then centrifuged at 1,000xg for 15 
minutes. 
The supernatants containing the excised pBluscript phagemid packaged as 
filamentous phage particles were transferred to new tubes and stored at 4°C. The 
excised phagemid was mixed with SOLR cells and plated on LB-ampicillin agar 
plates. In a 1.5 ml microcentrifuge tube, 1.0 µI of excised phage was added to 99 µI 
of SOLR cells and two more 1 :10 serial dilutions were made in 90 µI of SOLR cells. 
The tubes were incubated for 15 minutes at 37°C and the cells were plated on LB-
ampicillin agar plates. The plates were incubated at 37°C for overnight and then 
stored at 4°C. 
Isolation of plasmid DNA 
Plasmid DNA was isolated by alkaline lysis of bacteria using the Qiaprep spin 
miniprep kit as outlined by the manufacturer (Qiaprep, Qiagen Inc., USA). The 
excised single-stranded pbluescript phagemid (SK-) was rescued into double-
stranded pbluescript phagemid in SOLR cells plated on LB-ampicillin selecting agar 
plates and stored at 4°C. Such single bacterial colonies obtained from the listed 
picked plaques, 714P6A, 714P6B, 714P6C, 714P6D, 714P2A, 714P2B, 
pPSP714P2C, 714P3A, 714P3B, 714P4A, 714P4B, and 714P5A were separately 
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inoculated into 3 ml of LB-ampicillin broth and incubated at 37°C for overnight with 
continuous agitation. 
The bacterial cells were pelleted at 1,000xg for 10 minutes and resuspended 
in 250 µI of P1 buffer. The suspension was transferred to a new tube. The cells 
were lysed by adding 250 µI of alkaline lysis buffer P2. The tubes were gently 
inverted 4-6 times to mix and 350 µI of neutralizing buffer N3 was added. The tubes 
were immediately inverted 4-6 times. Centrifugation at 1 O,OOOxg was performed for 
10 minutes. 
The supernatants were decanted into Qiaprep spin columns (Qiagen) placed 
in 2 ml collecting tubes and centrifuged for 30-60 seconds. The flow-through was 
discarded and 0.5 ml of buffer PB was added to the column. Centrifugation at 
10,000xg was performed for 30 - 60 seconds to wash the columns. The flow-
through was discarded and 0.75 ml of buffer PE was added. The tubes were 
centrifuged at 1 O,OOOxg for 30-60 seconds. The flow-through was discarded and the 
tubes were centrifuged for another 60 seconds to remove residual washing buffer. 
The Qiaprep columns were transferred into 1.5 ml microcentrifuge tubes and 
50 µI of elution buffer EP (1 OmM Tris-HCI, pH-8.5) was added to the center of the 
columns. The columns were placed at room temperature for 5 minutes and then 
centrifuged for 1 minute to collect the DNA 
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Sequencing and nucleotide sequence analysis 
Several clones selected by hybridization with the virus specific probe were 
sequenced using universal (or oligo d(T)) and reverse primers by the Sanger 
dideoxy chain termination method using an automated fluorescent sequencer 
(Applied Biotechnologies, Foster City, CA). For the clone pPSP714P2C, further 
sequencing was done with primers designed from the sequence determined using 
reverse and universal primers. The walking of the insert was continued until the 
complete sequence was obtained. Two more internal primers derived from the 
sequences obtained were synthesized and used to further sequence the insert of 
clone pPSP714P2C. The sequencing strategy is shown in Figure 1. 
pSK-R pPSP714P2C INSERT pSK-L 
R U orpolyT 
U-1 L-1 
U-2 
L-2 
Figure 1. Sequencing strategy: pSK-L and pSK-R are the left and right arms, 
respectively, of the circular pbluescript (pSK) phagemid flanking the double-stranded 
insert pPSP714P2C derived from the viral cDNA. Reverse, universal and oligo d(T) 
are primers specific to the pbluescript phagemid (pSK). L-1 is a lower primer 
derived from the sequence obtained with the universal primer and L-2 is a lower 
primer derived from the sequence obtained with L-1 . The U-1 upper primer was 
derived from the sequence obtained with the reverse primer and U-2 upper primer 
was derived from the sequence obtained with U-1. A primer walking was done to 
complete the sequencing of the insert. 
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Sequence analysis was performed using MacVector (International 
Biotechnologies, New Haven, CT) and GeneWorks programs. Nucleotide sequence 
of the PK insert was used to search the database using the BLAST program. 
Results 
Electron microscopy of virions 
The electron micrographs of the purified virions obtained are shown in 
Figures 2a-e. Some of the various shapes of the PPMV virions observed are 
represented in the figures. The spherical virions with diameter of 150-400 nm were 
dominant in the samples (Figure 2d, 2e). Some filamentous forms were also 
observed (Figure 2b). Virions with several projections were observed (Figure 2c). 
Nucleocapsids were also seen protruding from a disrupted virion envelopes (Figure 
2a) in a sample prepared from virion pellets resuspended in water. A relatively 
smaller number of disrupted virions was seen in samples from pellets re-suspended 
in TEN buffer (pH 8.0). In general, the electron micrographs showed the varying 
shapes of the virions. The diameter of the virions measured from 150-400 nm. The 
length of the filamentous forms was up to 0.7µm. In all virions, projections of 
apparent uniform length (not measured) surrounding the virion were present. These 
projections extended from a denser demarcation that represents the envelope of the 
virus. 
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Figure 2. Electronmicrographs of PPMV virions: (a) two disrupted virions with 
protruding nucleocapsids; (b) two branching filamentous virions; (c) an irregularly 
shaped virion; (d) a spherical virion; and (e) differently shaped virions shown 
together. Each bar is 100 nm. 
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Electron microscopy of nucleocapcids 
An electron micrograph of nucleocapcids that banded in the layer of 30% 
CsCl2 of the gradient is shown in figure 3. More than 25 long nucleocapcids were 
measured and the average length was 0.71 µm. It was not possible to tell whether 
the nucleocapcids measured represented full length nucleocapcids. 
Figure 3. Electronmicrograph showing negatively stained nucleocapcids 
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Shorter strands of the nucleocapsids were abundant in the samples possibly 
representing fragments from full-length nucleocapsids or defective strands (Fig. 2). 
Cloning of cDNA 
A recombinant cDNA library was constructed from the reverse transcription 
product of RNA isolated from PPMV-infected vero cells followed by double-stranded 
cDNA synthesis. Approximately 1 :10 ratio of blue colonies with no insert to white 
colonies with insert was obtained indicating successful cloning. A single 
amplification of the cDNA library was performed. 
Hybridization and screening 
The cDNA library was screened for virus specific clones by hybridization with 
a random primed 32P-labeled cDNA probe prepared from virus-infected vero cells. 
The probe was specific as the 32P-labeled probe hybridized only to the virus infected 
cell RNA spotted on nitrocellulose membrane and not unto infected cell RNA. 
Secondary screening was performed on the twenty positive clones and sub-
clones were selected from each positive clone. Double stranded DNA was isolated 
from the sets of clones and analyzed. One of these clones, pPSP714P2C had an 
insert of about 1.9 Kb and was further characterized. 
Nucleotide sequencing of cDNA clones and analysis 
DNA from several clones representing similar size of DNA insert was 
sequenced. The partial sequence obtained from one clone, pPSP714P2C, using 
universal and reverse primers showed homology with that of bovine parainfluenza 
55 
virus type 3 P gene in the blast search. The blast search with the complete 
sequence of pPSP714P2 indicated some homology of this clone to the P genes of 
human parainfluenza virus type1, human parainfluenza virus type 3 and bovine 
parainfluenza virus 3, Sendai virus (HPIV 1 ), ovine parainfluenza virus and human 
parainfluenza virus type 48. The blast search gave the highest homology score for 
the BPIV-3/PIV-3 P genes. The homology of pPSP714P2C was 98% with BPIV-3 
(BY00114), 98% with PIV-3 (HD84095), 39% with HPIV-1 (M74082), and 49% with 
Sendai virus (X17008). 
The nucleotide sequence of the mRNA representing the P gene identified by 
the sequence of clone pPSP714P2C is shown in the positive sense in Figure 4. The 
coding sequence starts from position 52 and ends at position 1839. The mRNA is 
1962 nucleotides long followed by a poly-A tail and contains 3 open reading frames 
(ORFs). The largest ORF encoding 596 amino acids starts from position 52 and 
ends at position 1839. This largest ORF is 1788 nucleotides long and it encodes 596 
amino acids and has an estimated molecular mass (Mr) of 66,241 daltons. The 
second ORF is 603 nucleotides long encoding 201 amino acids and it starts from 
position 62 and ends at 664 with a calculated Mr 23,585 daltons. This ORF has 98% 
homology with the non-structural C protein of human parainfluenza virus type 3, 
strains Y00114, 084095, MNNZB3, 75% with strain U51116, 71 % with bovine 
parainfluenza (AF035681) virus C protein and 40% with C protein of human 
parainfluenza (M7 4081) virus 1. A third ORF encoding 140 amino acids was present 
but showed no homology with any other proteins. The sequence of the cloned ISU-
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AGCGGAGGGACAAATCCAGGATCCACCCAAAATTAACCAAACCAAAGATT 
CATGGAAAATAATGCTAAAGACAATCAAATCATGGATTCTTGGGAAGAGG 
GACCAGGAGACAAGTCATCTGACATCTCATCGGCCCTCGACATCATTGAA 
TTCATACTCAGCACCGACTCCCAAGAGAACACGGCAGACAGCAATGAAGT 
CAACACAGGAAACAAGAGACTCAGCACGACAATCTACCAACTTGAATCCA 
AAACAACAGAAACAAGCAAAGAAAATAGTGGATCAGTTAACGAAAATCGA 
CAGCTTGGGGCATCACACGAACGTGCCACAGAGACAAAGAATAGAAATGT 
TAATCAGGAGACTATACAGGGAGGAAATAGGGGAGGAAGCAGCTCAGATA 
GTAGAGCTGAGACTATGGTCACTCGAGGAATCTCCAGAAGCAGCCCAGAT 
TCTAACAATGGAACCCAAATCCAGGAAAGTATTGATTACAATGAAGTTGG 
AGAGATGGATAAGGACTCTGCTAAGAGGGAAATGCGACAGTCTAAAGATG 
TTCCAGTCAAGGTATCAAGAAGTGATGCCATTCCTCCAACAAAACAGGAT 
GGAAATGGTGATGATGGAAGAAGCATGGAATCTATCAGTACATTTGATTC 
AGGATATACCAGCATAGTGACTGCTGCAACATTGGATGATGAAGAAGAAC 
TCCTTATGAAGAACACCAGGCCAAGAAGATATCAGTCAACACCCCAGGAA 
GATGACAAGGGAATTAAAAAAGGGGTTGGAAAGCCAGAAGATACAAACAA 
ACAATCACCAACACTGGACTACGAACTCAACTCCAAAGGATCGAAGAGGA 
ACCAGAAGACCTCCGAAATCAGCACGACCACAGGGGAACCAACAAGACCA 
CAGAGTGGATCCCAAGGGAAGAGAATCACATCCTGGAACATCCTCAACAG 
CGAGAGCATCAGTCGAACAGAATCAACAAGCCAAAATCCTCAGACACCAA 
CATCTGGGAAGAGCAATACAGTGGGACCAGGCAGAACAACCCTCGAATCA 
AGAATCAAGACACAAAAGACGGATGGAAAGGAAAGAGAGGACACAGAAGA 
GAGCACTCGATTTACAGAAAGGGCGATTACATTATTACAGAATCTTGGTG 
CAATCCAATCTGCAGCAAAATTAGACCTATACCAAGACAAGAGAGTTGTG 
TGTGTGGCGAATGTCCTAAACAATGCGGATACTGCATCGAAGATAGACTT 
TCTAGCAGGTCTAATGATTGGAGTATCAATGGATCATGATACCAAATTAA 
ACCAGATTCAAAATGAGATATTAAGTTTAAAAACTGATCCCAAGAAGATG 
GATGAATCACATAGAAGATTAATTGAAAATCAAAAAGAACAATCATCACC 
GATTACATCATTGATCTCAAATCTTAAATTTATGACAGAGAGAGGAGGGA 
AGAAGGACCAATCCGAACACAGCGGAAGGACACCCATGATCAAGACAAAA 
GCAAAAGAAGAGAAAATAAAGAAAGTCAGGTTTGATCCTCTTATGGAAAC 
ACAGGGTATCGAGAAAAATATCCCTGACCTCTATAGATCAATAGAGAAAA 
CACCAGAAAACGACATACAGATCAAATCAGACATAAACAGATCGAATGAT 
GAGTCCAATGCAACTAGACTGGTACCCAAGAGAACAAGCAATACAATGAG 
ATCACTAATCATAATCATCAACAACAGCAATTTGTCATCAAGAGCAAAGC 
AGTCATATATCAACGAACTCAAGCTCTGCAAGAGTGACGAAGAAGTGTCC 
GAGTTGATGGACATGTTCAATGAGGATGTCAGCTCTCAGTAAACAACCAA 
CCAAGGATCCACCTCACAGAAATCAACAGCACAAGATAACTAACCAGAGA 
TCAACCCGAAACACCAGACCAAACAACACACAGCAAACGCCCTCCAATCA 
CAGCTGATTAAGAAAAAAAAAAAA 
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Figure 4. The nucleotide sequence of the mRNA representing the P gene 
of PPMV (ISU-92) identified by the sequence of clone pPSP714P2C. 
ATG and T AA (in bold) represent start and stop codons, respectively. 
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92 mRNA was compared to the genome of the BPIV-3 (15,548 nucleotides) and it 
was found to correspond to the region between nucleotides 1,732 and 3,699. This 
region of the BPIV-3 includes the P gene coding sequence. A comparison of the 
coding sequences revealed that both are1791 nucleotides long with a homology of 
98% between the ISU-92 and BPIV-3 P genes. The overall homology between the 
P genes of ISU-92 and BPIV-3 was 97% and the non-coding regions had 83% 
homology. There were 58 nucleotide changes in the mRNA of PPMV representing 
3% of the total number of nucleotides. In the coding sequence there were a total of 
48 nucleotide changes amounting to 2% of the total number of nucleotides in the 
coding region. The alignments of the PPMV and BPIV3 mRNAs are shown in 
Figure 5. 
BIPV 3 
PPMV P 
BIPV 3 
GACGGAGGGACAAATCCAGAATCCACCCACGACCAACCAAACCAAAGATTCATGGAAAACAATGCTAAAGACAAT 1807 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
AGCGGAGGGACAAATCCAGGATCCACCCAAAATTAACCAAACCAAAGATTCATGGAAAATAATGCTAAAGACAAT 75 
CAAATCATGGATTCTTGGGAAGAGGGATCAGGAGACAAGTCATCTGACATCTCATCGGCCCTCGACATCATTGAA 1882 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
PPMV CAAATCATGGATTCTTGGGAAGAGGGACCAGGAGACAAGTCATCTGACATCTCATCGGCCCTCGACATCATTGAA 150 
BIPV 3 
PPMV P 
BIPV 3 
PPMV P 
BIPV 3 
PPMV P 
BIPV 3 
PPMV P 
BIPV 3 
PPMV P 
BIPV 3 
PPMV P 
BIPV 3 
PPMV P 
BIPV 3 
PPMV P 
BIPV 3 
PPMV P 
TTCATACTCAGCACCGACTCCCAAGAGAACACGGCAGACAGCAATGAAGTCAACACAGGGAACAAGAGACTCAGC 1957 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
TTCATACTCAGCACCGACTCCCAAGAGAACACGGCAGACAGCAATGAAGTCAACACAGGAAACAAGAGACTCAGC 225 
ACGACAATCTACCAACTTGAATCCAAAACAACAGAAACAAGCAAAGAAAATAGTGGATCAGTTAACGAAAATCGA 2032 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
ACGACAATCTACCAACTTGAATCCAAAACAACAGAAACAAGCAAAGAAAATAGTGGATCAGTTAACGAAAATCGA 300 
CAGCTTGGGGCATCACACGAACGTGCCACAGAGACAAAGAATAGAAATGTTAATCAGGAGACTATACAGGGAGGA 2107 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
CAGCTTGGGGCATCACACGAACGTGCCACAGAGACAAAGAATAGAAATGTTAATCAGGAGACTATACAGGGAGGA 375 
AATAGGGGAAGAAGCAGCTCAGATAGTAGAGCTGAGATTATGGTCACTCGAGGAATCTCCAGAAGCAGCCCAGAT 2182 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
AATAGGGGAGGAAGCAGCTCAGATAGTAGAGCTGAGACTATGGTCACTCGAGGAATCTCCAGAAGCAGCCCAGAT 450 
CCTAACAATGGAACCCAAATCCAGGAAAGTATTGATTACAATGAAGTTGGAGAGATGGATAAGGACTCTGCTAAG 2257 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
TCTAACAATGGAACCCAAATCCAGGAAAGTATTGATTACAATGAAGTTGGAGAGATGGATAAGGACTCTGCTAAG 525 
AGGGAAATGCGACAATCTAAAGATGTTCCAGTCAAGGTATCAAGAAGTGATGCCATTCCTCCAACAAAACAAGAT 2332 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
AGGGAAATGCGACAGTCTAAAGATGTTCCAGTCAAGGTATCAAGAAGTGATGCCATTCCTCCAACAAAACAGGAT 600 
GGAAACGGTGATGATGGAAGAAGCATGGAATCTATCAGTACATTTGATTCAGGATATACCAGCATAGTGACTGCT 2407 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
GGAAATGGTGATGATGGAAGAAGCATGGAATCTATCAGTACATTTGATTCAGGATATACCAGCATAGTGACTGCT 675 
GCAACATTGGATGATGAAGAAGAACTCCTTATGAAGAACACCAGGCCAAAAAGATATCAGTCAACACCCCAGGAA 2482 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
GCAACATTGGATGATGAAGAAGAACTCCTTATGAAGAACACCAGGCCAAGAAGATATCAGTCAACACCCCAGGAA 750 
GATGACAAGGGAATTAAAAAAGGGGTTGGAAAGCCAGAAGATACAAACAAACAATCACCAATATTGGACTACGAA 2557 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
GATGACAAGGGAATTAAAAAAGGGGTTGGAAAGCCAGAAGATACAAACAAACAATCACCAACACTGGACTACGAA 825 
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CTCAACTCCAAAGGATCGAAGAGGAACCAGAAGACCCTCAAAATCAGCACGACCACAGGGGAATCAACAAGACCA 2 632 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
CTCAACTCCAAAGGATCGAAGAGGAACCAGAAGACCTCCGAAATCAGCACGACCACAGGGGAACCAACAAGACCA 9 00 
CAGAGTGGATCCCAAGGGAAGAGAATCACATCCTGGAACATCCTCAACAGCGAGAGCGGCAGTCGAACAGAATCA 2 707 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
CAGAGTGGATCCCAAGGGAAGAGAATCACATCCTGGAACATCCTCAACAGCGAGAGCATCAGTCGAACAGAATCA 975 
ACAAGCCAAAACTCTCAGATACCAACATCTGGGAAGAGCAATACAGTGGGACCAGGCAGAACAACTCTCGAATCA 2 78 2 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
ACAAGCCAAAATCCTCAGACACCAACATCTGGGAAGAGCAATACAGTGGGACCAGGCAGAACAACCCTCGAATCA 105 0 
AGGATCAAGACACAAAAGACGGATGGAAAGGAAAGAGAGGACACAGAAGAGAGCACTCGATTTACAGAGAGGGCG 285 7 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
AGAATCAAGACACAAAAGACGGATGGAAAGGAAAGAGAGGACACAGAAGAGAGCACTCGATTTACAGAAAGGGCG 1 125 
ATTACATTATTACAGAATCTTGGTGTAATCCAATCTGCAGCAAAATTAGACCTGTACCAAGACAAGAGAGTTGTG 293 2 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : ! : : : : : : : : 
ATTACATTATTACAGAATCTTGGTGCAATCCAATCTGCAGCAAAATTAGACCTATACCAAGACAAGAGAGTTGTG 1200 
TGTGTGGCGAATGTCCTAAACAATGCGGATACTGCATCGAAGATAGACTTTCTAGCAGGTCTAATGATTGGAGTA 3 007 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
TGTGTGGCGAATGTCCTAAACAATGCGGATACTGCATCGAAGATAGACTTTCTAGCAGGTCTAATGATTGGAGTA 1 275 
TCAATGGATCATGATACCAAATTAAACCAGATTCAGAATGAGATATTAAGTTTAAAAACTGATCTTAAGAAGATG 3 0 82 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
TCAATGGATCATGATACCAAATTAAACCAGATTCAAAATGAGATATTAAGTTTAAAAACTGATCCCAAGAAGATG 1350 
GATGAATCACATAGAAGATTAATTGAAAATCAAAAAGAACAATTATCACTGATCACATCATTGATCTCAAATCTT 3157 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
GATGAATCACATAGAAGATTAATTGAAAATCAAAAAGAACAATCATCACCGATTACATCATTGATCTCAAATCTT 1425 
AAAATTATGACAGAGAGAGGAGGGAAGAAGGACCAACCCGAAAACAGCGGAAGGACACCCATGATCAAGACGAAA 3232 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
AAATTTATGACAGAGAGAGGAGGGAAGAAGGACCAATCCGAACACAGCGGAAGGACACCCATGATCAAGACAAAA 1 5 00 
GCAAAAGAAGAGAAAATAAAGAAAGTCAGGTTTGATCCTCTTATGGAAACACAGGGTATCGAGAAAAACATCCCC 3 307 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
GCAAAAGAAGAGAAAATAAAGAAAGTCAGGTTTGATCCTCTTATGGAAACACAGGGTATCGAGAAAAATATCCCT 1 575 
GACCTCTATAGATCAATAGAGAAAACACCAGAAAACGACATACAGATCAAATCAGACATAAACAGATCGAATGAT 3382 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
GACCTCTATAGATCAATAGAGAAAACACCAGAAAACGACATACAGATCAAATCAGACATAAACAGATCGAATGAT 1650 
GAGTCCAATGCAACCAGACTGGTACCCAAGAGAACAAGCAATACAATGAGATCACTAATCATAATCATCAACAAC 3 457 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
GAGTCCAATGCAACTAGACTGGTACCCAAGAGAACAAGCAATACAATGAGATCACTAATCATAATCATCAACAAC 1 725 
AGCAATTTGTCATCAAGAGCAAAGCAGTCATATATCAACGAACTCAAGCTCTGCAAGAGTGACGAAGAAGTGTCC 3532 
: : : ! ! : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
AGCAATTTGTCATCAAGAGCAAAGCAGTCATATATCAACGAACTCAAGCTCTGCAAGAGTGACGAAGAAGTGTCC 1 8 00 
GAGTTGATGGACATGTTCAACGAGGATGTCAGCTCTCAGTAAACAGCCAACCAAGGATCCACCTCACAGAAATCA 36 07 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
GAGTTGATGGACATGTTCAATGAGGATGTCAGCTCTCAGTAAACAACCAACCAAGGATCCACCTCACAGAAATCA 1875 
ACAGCACAAGACAACCAACCAGAGATCACCCCAAAACACCAGACTAAACAATACACAGCAAACACCCTCCAATCA 3682 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : 
ACAGCACAAGATAACTAACCAGAGATCAACCCGAAACACCAGACCAAACAACACACAGCAAACGCCCTCCAATCA 1950 
CAGCTGATTAAGAAAAACTTAGGA 37 06 
: : : : : : : : : : : : : : : : : 
CAGCTGATTAAGAAAAAAAAAAAA 1974 
Figure 5. The alignments of the sequence obtained from clone pPSP714P2C 
representing the mRNA of the PPMV P gene with that of the BPIV 3 P gene. Paired 
dots show homology and blank spaces show mismatches. 
Discussion 
We have characterized the ultrastructure of the ISU-92 strain of PPMV which 
confirms previous studies that ISU-92 is a paramyxovirus. The pleomorphic nature 
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1966). Filamentous forms of the virions have also been reported for the rinderpest 
virus (Plowright, 1962). Surface projections representing the spikes observed were 
a common feature of the virions and have been observed in other viruses (Greig, 
1971 ). The diameter of virions observed in our study ranged between 150-400 nm 
which is similar to 150-500 nm reported for paramyxoviruses (Nagai et al., 1989, 
cited in Lamb, 1996). The serrated nucleocapsids are similar to the serration 
demonstrated for the LPMV, mumps, Sendai and Newcastle disease viruses 
(Kolakofsky, 1974; Heggeness et al., 1980; Nagai et al., 1989; Sundqvist et al., 
1990). 
The variable forms of the PPMV virion demonstrated by electron microscopy 
and the morphology of the nucleocapsids observed strongly suggest that ISU-92 is a 
paramyxovirus. In conjunction with the antigenic reactivity with the BPIV- 3 and 
HPIV-3, (Janke et al., 1992), it is suggested that ISU-92 is a PPMV and a member of 
the genus paramyxovirus. However additional studies are warranted to conclusively 
demonstrate its relationship to other paramyxoviruses. 
The P protein of paramyxoviruses is required for the formation of a fully active 
transcriptive complex during replication (Hamaguchi et al., 1983). It is, therefore, 
expected that the mRNA representing the P gene should be found in relatively high 
abundance during the replication of the paramyxoviruses. Since the cDNA we used 
for cloning was obtained from infected cells in which virus replication was actively 
taking place, it is no surprise that the first positive clone we obtained corresponded 
to the P gene mRNA. 
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The number of amino acids coded for by the P genes of the paramyxoviruses 
and the morbilliviruses range from 507 to 603 (Lamb and Kolakofsky, 1996). 
Analysis of the ISU-92 P gene showed that it encodes 596 amino acids. There are 
51 untranslated nucleotides before the start (AUG) of the largest ORF. However, 
there is no evidence at this time to conclude that the non-coding sequence of the P 
gene mRNA is only 51 nucleotides long. The high nucleotide homology of 98% 
between the ISU-92 and BPIV-3 suggests a close relationship of ISU-92 with BPIV-
3. Lower homology was also detected with the P proteins of other paramyxoviruses. 
The RNA dependent RNA polymerases of single-stranded ( +) RNA viruses have 
conserved motifs but these polymerases have been shown to share homology with 
other distantly related viruses (Koonin and Dolja, 1993). Therefore, there is the 
need to sequence other genes of the porcine paramyxovirus for its classification. 
However, based on the high nucleotide homology of 98% between ISU-92 
and BPIV 3, it is clear that the ISU-92 is closely related to the BPIV-3 group of 
viruses. It is our opinion that the ISU-92 should be classified in the family 
Paramyxoviridae, sub-family Paramyxovirinae and the genus paramyxovirus. It is 
possible that the BPIV-3 through mutation has become adapted to a new host. The 
plasmid pPSP714P2C containing the P gene should be beneficial in development of 
an in situ hybridization test for the detection of PPMV in tissues. 
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CHAPTER 3. GENERAL CONCLUSIONS 
The porcine paramyxovirus, ISU-92 was isolated from pigs in 1992. The 
disease outbreak from which the virus was isolated was characterized by respiratory 
and CNS disorders with the tendency to spread rapidly within the population. The 
disease has been reproduced using cell culture propagated ISU-92 by intranasal 
inoculation of 3 day-old piglets resulting in mild pneumonia. A virus neutralization 
test that was developed and used in screening serum for the presence of antibodies 
to PPMV detected only a low level of PPMV infection in the population studied. The 
PPMV was also shown to be antigenically related to PIV-3, BPIV3 and PIV-48, 
although reactivity with PIV-48 was low. 
In this study, we continued the characterization of ISU-92 and started the 
molecular characterization of ISU-92. The virions of the porcine paramyxovirus were 
found to show variability in their morphology. This is in agreement with the 
pleomorphism that has been established as a characteristic of paramyxoviruses. 
The virion diameter of 150-400 nm observed falls within the range of diameter of 
paramyxoviruses. These characteristics of ISU-92 strongly support our prediction 
that ISU-92 is a paramyxovirus. 
We have successfully cloned the total mRNA of vero cells infected with ISU-
92 into the lambda derived cloning vector Uni-Zap XR. An efficient probe developed 
from infected cells was used to select a virus specific clone, pPSP714P2C from the 
cDNA library. The sequence of this clone gave the first information about the 
genome of ISU-92. By sequence comparison, we identified the sequence to be 
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representative of the mRNA for the P gene. The ISU-92 P gene had 98% nucleotide 
homology with BPIV-3 and HPIV-3. In a comparison of this sequence to the P gene 
of the LPMV only 13% homology was observed. This observation is consistent with 
lack of biological reactivity with antiserum to LPMV. The high homology with the 
PIV-3 and BPIV-3 was not expected and raises several questions. Is the ISU-92 a 
true porcine paramyxovirus? If so, how and where has it evolved from? Did this 
originate from BPIV 3? Which species are susceptible to this virus? 
In order to answer these questions additional studies need to be conducted. 
First the whole genome of ISU-92 needs to be sequenced. It is our opinion that the 
development of more sensitive tests, than those currently available, will clarify and 
help understand the epidemiology of this virus. 
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